000001543418false--11-302023Q3UnlimitedUnlimited0001543418tmq:ContributedSurplusMember2022-12-012023-02-280001543418us-gaap:CommonStockMember2022-06-012022-08-310001543418us-gaap:CommonStockMember2022-03-012022-05-310001543418us-gaap:RetainedEarningsMember2023-08-310001543418tmq:ContributedSurplusUnitsMember2023-08-310001543418tmq:ContributedSurplusStockbasedCompensationMember2023-08-310001543418tmq:ContributedSurplusMember2023-08-310001543418us-gaap:RetainedEarningsMember2023-05-310001543418tmq:ContributedSurplusUnitsMember2023-05-310001543418tmq:ContributedSurplusStockbasedCompensationMember2023-05-310001543418tmq:ContributedSurplusMember2023-05-3100015434182023-05-310001543418us-gaap:RetainedEarningsMember2023-02-280001543418tmq:ContributedSurplusUnitsMember2023-02-280001543418tmq:ContributedSurplusStockbasedCompensationMember2023-02-280001543418tmq:ContributedSurplusMember2023-02-2800015434182023-02-280001543418us-gaap:RetainedEarningsMember2022-11-300001543418tmq:ContributedSurplusUnitsMember2022-11-300001543418tmq:ContributedSurplusStockbasedCompensationMember2022-11-300001543418tmq:ContributedSurplusMember2022-11-300001543418us-gaap:RetainedEarningsMember2022-08-310001543418tmq:ContributedSurplusUnitsMember2022-08-310001543418tmq:ContributedSurplusStockbasedCompensationMember2022-08-310001543418tmq:ContributedSurplusMember2022-08-310001543418us-gaap:RetainedEarningsMember2022-05-310001543418tmq:ContributedSurplusUnitsMember2022-05-310001543418tmq:ContributedSurplusStockbasedCompensationMember2022-05-310001543418tmq:ContributedSurplusMember2022-05-3100015434182022-05-310001543418us-gaap:RetainedEarningsMember2022-02-280001543418tmq:ContributedSurplusUnitsMember2022-02-280001543418tmq:ContributedSurplusStockbasedCompensationMember2022-02-280001543418tmq:ContributedSurplusMember2022-02-2800015434182022-02-280001543418us-gaap:RetainedEarningsMember2021-11-300001543418tmq:ContributedSurplusUnitsMember2021-11-300001543418tmq:ContributedSurplusStockbasedCompensationMember2021-11-300001543418tmq:ContributedSurplusMember2021-11-300001543418us-gaap:CommonStockMember2023-05-310001543418us-gaap:CommonStockMember2023-02-280001543418us-gaap:CommonStockMember2022-08-310001543418us-gaap:CommonStockMember2022-05-310001543418us-gaap:CommonStockMember2022-02-280001543418us-gaap:CommonStockMember2021-11-300001543418us-gaap:CommonStockMember2023-04-250001543418us-gaap:EmployeeStockOptionMember2023-08-310001543418us-gaap:EmployeeStockOptionMember2022-11-300001543418srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMemberus-gaap:SubsequentEventMember2023-09-012023-09-010001543418srt:DirectorMembertmq:DeferredStockUnitsDsusMemberus-gaap:SubsequentEventMember2023-09-012023-09-010001543418tmq:EmployeesConsultantsAndDirectorsMember2023-06-012023-08-310001543418tmq:EmployeesConsultantsAndDirectorsMember2023-03-012023-05-310001543418tmq:EmployeesConsultantsAndDirectorsMember2021-12-012022-02-280001543418us-gaap:EmployeeStockOptionMember2022-12-012023-08-310001543418tmq:RangeTwoMember2023-08-310001543418tmq:RangeSixMember2023-08-310001543418tmq:RangeFourMember2023-08-310001543418tmq:RangeFiveMember2023-08-310001543418us-gaap:RestrictedStockUnitsRSUMember2023-08-310001543418tmq:NumberOfDsusMember2023-08-310001543418us-gaap:RestrictedStockUnitsRSUMember2022-11-300001543418tmq:NumberOfDsusMember2022-11-300001543418us-gaap:RestrictedStockUnitsRSUMember2022-12-012023-08-310001543418tmq:EmployeesConsultantsAndDirectorsMember2022-12-012023-02-280001543418tmq:ContributedSurplusUnitsMember2023-06-012023-08-310001543418tmq:ContributedSurplusStockbasedCompensationMember2023-06-012023-08-310001543418tmq:ContributedSurplusStockbasedCompensationMember2023-03-012023-05-310001543418tmq:NumberOfDsusMember2022-12-012023-08-310001543418tmq:DirectorsEmployeesAndServicesProvidersMember2022-12-012023-08-310001543418tmq:ContributedSurplusUnitsMember2022-12-012023-02-280001543418tmq:ContributedSurplusStockbasedCompensationMember2022-12-012023-02-280001543418tmq:ContributedSurplusUnitsMember2022-06-012022-08-310001543418tmq:ContributedSurplusStockbasedCompensationMember2022-06-012022-08-310001543418tmq:ContributedSurplusUnitsMember2022-03-012022-05-310001543418tmq:ContributedSurplusStockbasedCompensationMember2022-03-012022-05-310001543418tmq:NumberOfDsusMember2021-12-012022-08-310001543418tmq:DirectorsEmployeesAndServicesProvidersMember2021-12-012022-08-310001543418tmq:ContributedSurplusUnitsMember2021-12-012022-02-280001543418tmq:ContributedSurplusStockbasedCompensationMember2021-12-012022-02-280001543418tmq:NovaGoldArrangementMembertmq:DirectorsEmployeesAndServicesProvidersMember2022-12-012023-08-310001543418us-gaap:RetainedEarningsMember2023-06-012023-08-310001543418us-gaap:RetainedEarningsMember2023-03-012023-05-3100015434182023-03-012023-05-310001543418us-gaap:RetainedEarningsMember2022-12-012023-02-280001543418us-gaap:RetainedEarningsMember2022-06-012022-08-310001543418us-gaap:RetainedEarningsMember2022-03-012022-05-3100015434182022-03-012022-05-310001543418us-gaap:RetainedEarningsMember2021-12-012022-02-280001543418tmq:South32LimitedMember2020-02-110001543418tmq:CanadianLimitDueToCurrencyRiskMember2022-12-012023-08-310001543418tmq:AmblerMetalsLlcMember2022-11-300001543418tmq:South32LimitedMembertmq:AmblerMetalsLlcMember2023-08-310001543418tmq:South32LimitedMembertmq:AmblerMetalsLlcMember2020-02-110001543418tmq:AmblerMetalsLlcMember2020-02-110001543418tmq:AmblerMetalsLlcMember2023-08-310001543418tmq:NonvestedOptionsMember2023-08-310001543418tmq:AmblerMetalsLlcMember2023-06-012023-08-310001543418tmq:AmblerMetalsLlcMember2022-12-012023-08-310001543418tmq:AmblerMetalsLlcMember2022-06-012022-08-310001543418tmq:AmblerMetalsLlcMember2021-12-012022-08-310001543418tmq:NovaGoldArrangementMembertmq:NonvestedOptionsMembertmq:DirectorsEmployeesAndServicesProvidersMember2023-08-3100015434182021-12-012022-11-3000015434182022-08-3100015434182021-11-3000015434182023-06-012023-08-310001543418us-gaap:SubsequentEventMember2023-09-010001543418us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2023-08-310001543418us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-11-3000015434182022-06-012022-08-3100015434182022-12-012023-02-2800015434182021-12-012022-02-280001543418us-gaap:CommonStockMember2022-12-012023-02-280001543418us-gaap:CommonStockMember2021-12-012022-02-280001543418tmq:RangeTwoMember2022-12-012023-08-310001543418tmq:RangeSixMember2022-12-012023-08-310001543418tmq:RangeFourMember2022-12-012023-08-310001543418tmq:RangeFiveMember2022-12-012023-08-310001543418us-gaap:CommonStockMember2023-04-252023-04-250001543418tmq:AmblerMetalsLlcMember2020-02-112020-02-110001543418us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2023-06-012023-08-310001543418us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-12-012023-08-310001543418us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-06-012022-08-310001543418us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-12-012022-08-3100015434182021-12-012022-08-310001543418srt:DirectorMembertmq:DeferredStockUnitsDsusMemberus-gaap:SubsequentEventMember2023-09-010001543418us-gaap:CommonStockMember2023-06-012023-08-310001543418tmq:ContributedSurplusMember2023-06-012023-08-310001543418us-gaap:CommonStockMember2022-12-012023-08-310001543418us-gaap:CommonStockMember2023-03-012023-05-310001543418tmq:ContributedSurplusUnitsMember2023-03-012023-05-3100015434182022-11-300001543418us-gaap:LeaseAgreementsMember2023-08-310001543418us-gaap:AccountsPayableAndAccruedLiabilitiesMember2023-08-3100015434182023-08-310001543418tmq:OnePercentChangeInInterestRatesMember2023-08-310001543418tmq:CanadianLimitDueToCurrencyRiskMember2023-08-310001543418srt:ManagementMemberus-gaap:RestrictedStockUnitsRSUMemberus-gaap:SubsequentEventMember2023-09-010001543418us-gaap:CommonStockMember2023-08-310001543418us-gaap:CommonStockMember2022-11-3000015434182023-10-1100015434182022-12-012023-08-31xbrli:sharesiso4217:USDxbrli:puretmq:Owneriso4217:CADiso4217:USDxbrli:sharesiso4217:CADxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended August 31, 2023

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from to

Commission File Number: 1-35447

Graphic

TRILOGY METALS INC.

(Exact Name of Registrant as Specified in Its Charter)

British Columbia

98-1006991

(State or Other Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer

Identification No.)

Suite 1150, 609 Granville Street

Vancouver, British Columbia
Canada

V7Y 1G5

(Address of Principal Executive Offices)

(Zip Code)

(604) 638-8088

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Shares

TMQ

NYSE American

Toronto Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of October 11, 2023, the registrant had 155,883,843 Common Shares, no par value, outstanding.

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

Trilogy Metals Inc.

Interim Consolidated Balance Sheets

(unaudited)

in thousands of US dollars

August 31, 2023

November 30, 2022

  

  

$

  

  

$

  

Assets

  

  

Current assets

  

  

Cash

3,049

2,573

Accounts receivable

10

17

Deposits and prepaid amounts

457

320

Total current assets

3,516

2,910

Investment in Ambler Metals LLC (note 3)

136,867

142,754

Fixed assets

6

12

Right of use asset (note 5 (a))

188

319

Total assets

140,577

145,995

Liabilities

  

  

Current liabilities

  

  

Accounts payable and accrued liabilities (note 4)

482

345

Current portion of lease liability

82

189

Total current liabilities

564

534

Long-term portion of lease liability

33

Total liabilities

564

567

Shareholders’ equity

  

  

Share capital (note 6) – unlimited common shares authorized, no par value issued – 155,559,334 (2022 – 145,868,502)

187,715

182,178

Contributed surplus

118

122

Contributed surplus – options (note 6(b))

28,111

27,352

Contributed surplus – units (note 6(c))

2,858

2,638

Deficit

(78,789)

(66,862)

Total shareholders' equity

140,013

145,428

Total liabilities and shareholders' equity

140,577

145,995

Commitments (note 8)

(See accompanying notes to the interim consolidated financial statements)

/s/ Tony Giardini, President, CEO and Director

 

/s/ Diana Walters, Director

 

 

 

Approved on behalf of the Board of Directors

 

 

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

3

Trilogy Metals Inc.

Interim Consolidated Statements of Loss

and Comprehensive Loss

(unaudited)

in thousands of US dollars, except share and per share amounts

For the three months ended

For the nine months ended

 

August 31, 2023

August 31, 2022

August 31, 2023

August 31, 2022

  

    

$

  

  

$

  

  

$

  

  

$

Expenses

  

 

  

  

 

  

Amortization

2

4

6

 

15

Exploration expenses

22

11

23

11

Foreign exchange (gain) loss

3

(11)

1

 

(7)

General and administrative

278

279

1,014

 

1,014

Investor relations

18

18

71

 

155

Professional fees

139

131

897

 

568

Salaries

191

172

621

 

847

Salaries and directors expense – stock-based compensation

526

562

3,379

 

3,146

Total expenses

1,179

 

1,166

6,012

 

5,749

Other items

  

 

  

  

 

  

Gain on disposition of mineral property

(84)

 

(84)

Interest and other income

(37)

(11)

(83)

 

(15)

Share of loss on equity investment (note 3(b))

2,910

8,925

5,998

13,295

Write off mineral properties

(58)

90

Loss and comprehensive loss for the period

(4,052)

 

(9,938)

(11,927)

 

(19,035)

Basic loss per common share

(0.03)

(0.07)

(0.08)

(0.13)

Diluted loss per common share

(0.03)

(0.07)

(0.08)

(0.13)

Basic weighted average number of common shares outstanding

155,550,284

145,865,847

151,572,299

145,555,376

Diluted weighted average number of common shares outstanding

155,550,284

145,865,847

151,572,299

145,555,376

(See accompanying notes to the interim consolidated financial statements)

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

4

Trilogy Metals Inc.

Interim Consolidated Statements of Changes in Shareholders’ Equity

(unaudited)

in thousands of US dollars, except share amounts

    

Contributed

Contributed

    

Total

 

Contributed

surplus –

surplus –

shareholders’

 

Number of shares

Share capital

surplus

options

units

Deficit

equity

  

outstanding

  

  

$

  

  

$

  

  

$

  

  

$

  

  

$

  

  

$

   

Balance – November 30, 2021

 

145,009,811

180,820

 

122

 

25,990

 

1,712

 

(42,605)

166,039

Exercise of options

 

31,674

50

 

 

(32)

 

 

18

Restricted Share Units

 

391,332

650

(650)

Joint venture contribution

31,469

51

51

Stock-based compensation

 

864

1,001

1,865

Loss for the period

 

 

 

 

 

(5,023)

(5,023)

Balance – February 28, 2022

 

145,464,286

181,571

 

122

 

26,822

 

2,063

 

(47,628)

162,950

Exercise of options

50,000

26

10

36

Restricted Share Units

110,000

113

(113)

Stock-based compensation

274

229

503

Loss for the period

(4,074)

(4,074)

Balance – May 31, 2022

145,624,286

181,710

122

27,106

2,179

(51,702)

159,415

Restricted Share Units

244,216

235

(235)

Stock-based compensation

221

350

571

Loss for the period

(9,938)

(9,938)

Balance - August 31, 2022

145,868,502

181,945

122

27,327

2,294

(61,640)

150,048

Balance – November 30, 2022

146,225,035

182,178

122

27,352

2,638

(66,862)

145,428

Restricted Share Units

 

2,346,366

1,538

(1)

(1,537)

Joint venture contribution

143,505

111

111

Services settled by common shares

7,793

4

4

Stock-based compensation

 

520

1,700

2,220

Loss for the period

(5,072)

(5,072)

Balance – February 28, 2023

148,722,699

183,831

121

27,872

2,801

(71,934)

142,691

Shares issued for private placement, net of share issue cost

5,854,545

3,115

3,115

Restricted Share Units

213,463

121

121

Deferred Share Units conversion

415,056

468

(468)

Services settled by common shares

63,533

35

35

Stock-based compensation

114

257

371

Loss for the period

 

(2,803)

(2,803)

Balance – May 31, 2023

 

155,269,296

187,570

 

121

 

27,986

 

2,590

 

(74,737)

143,530

Restricted Share Units

248,092

122

122

Services settled by common shares

40,816

20

20

NovaGold deferred share units conversion

1,130

3

(3)

Stock-based compensation

125

268

393

Loss for the period

 

(4,052)

(4,052)

Balance – August 31, 2023

 

155,559,334

187,715

 

118

 

28,111

 

2,858

 

(78,789)

140,013

(See accompanying notes to the interim consolidated financial statements)

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

5

Trilogy Metals Inc.

Interim Consolidated Statements of Cash Flows

(unaudited)

in thousands of US dollars

For the nine months ended

August 31, 2023

August 31, 2022

    

$

  

  

$

  

Cash flows used in operating activities

  

 

  

Loss for the period

(11,927)

 

(19,035)

Adjustments to reconcile net loss to cash flows in operating activities

 

  

Amortization

6

 

15

Professional fees settled by common shares

86

Office lease accounting

(9)

(13)

Gain on disposal of mineral property

(84)

Loss on equity investment in Ambler Metals LLC (note 3(b))

5,998

13,295

Unrealized foreign exchange loss (gain)

5

 

(1)

Stock-based compensation

3,379

 

2,939

Write off mineral properties

90

Net change in non-cash working capital

 

  

Decrease in accounts receivable

7

 

8

Increase in deposits and prepaid amounts

(137)

 

(231)

Decrease in accounts payable and accrued liabilities

(42)

 

(350)

Total cash flows used in operating activities

(2,634)

 

(3,367)

Cash flows from financing activities

  

 

  

Issuance of common shares, net of share issue cost (note 6(a))

3,115

 

Proceeds from exercise of options

54

Total cash flows from financing activities

3,115

 

54

Cash flows from investing activities

  

 

  

Proceeds from disposition of mineral property

 

142

Total cash flows from investing activities

 

142

Increase (decrease) in cash

481

 

(3,171)

Effect of exchange rate on cash

(5)

 

(4)

Cash – beginning of the period

2,573

 

6,308

Cash – end of the period

3,049

 

3,133

(See accompanying notes to the interim consolidated financial statements)

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

6

Table of contents

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

1)    Nature of operations

Trilogy Metals Inc. (“Trilogy” or the “Company”) was incorporated in British Columbia under the Business Corporations Act (British Columbia) on April 27, 2011. The Company is engaged in the exploration and development of mineral properties, through our equity investee (see note 3), with a focus on the Upper Kobuk Mineral Projects (“UKMP”), including the Arctic and Bornite Projects located in Northwest Alaska in the United States of America (“US”). The Company also conducts early-stage exploration through a wholly owned subsidiary, 995 Exploration Inc.  

2)    Summary of significant accounting policies

Basis of presentation

These interim consolidated financial statements have been prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Trilogy and its wholly owned subsidiaries, NovaCopper US Inc. (dba “Trilogy Metals US”) and 995 Exploration Inc. All intercompany transactions are eliminated on consolidation. For variable interest entities (“VIEs”) where Trilogy is not the primary beneficiary, we use the equity method of accounting.

All figures are in United States dollars unless otherwise noted. References to CDN$ refer to amounts in Canadian dollars.

These interim consolidated financial statements include all adjustments necessary for the fair presentation of the Company’s financial position as of August 31, 2023 and our results of operations and cash flows for the nine-month period ended August 31, 2023 and August 31, 2022. The results of operations for the nine-month period ended August 31, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending November 30, 2023.

As these interim consolidated financial statements do not contain all of the disclosures required by U.S. GAAP for annual financial statements, these interim consolidated financial statements should be read in conjunction with the annual financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended November 30, 2022, filed with the U.S. Securities and Exchange Commission (“SEC”) and Canadian securities regulatory authorities on February 14, 2023.

These interim consolidated financial statements were approved by the Company’s Audit Committee on behalf of the Board of Directors for issue on October 10, 2023.

Use of estimates and measurement uncertainties

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions of future events that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of expenditures during the period. Significant judgments include the assessment of potential indicators of impairment for our equity method investments where key judgement is the delay on the Ambler Access Project is temporary and the delay was considered when assessing indicators of impairment. Significant estimates include the measurement of income taxes, and the valuation of stock-based compensation. Actual results could differ materially from those reported.

Management assesses the possibility of impairment in the carrying value of its equity method investment in Ambler Metals whenever events or circumstances indicate that the carrying amount of the investment may not be recoverable. Significant judgments are made in assessing the possibility of impairment. Factors that may be indicative of an impairment include a loss in the value of an investment that is not temporary. Management considers several factors in considering if an indicator of impairment has occurred, including but not limited to, sustained losses by the investment, the absence of the ability to recover the carrying amount of the investment, significant changes in the legal, business or regulatory environment, significant adverse changes impacting the investee and internal reporting indicating the economic performance of an investment is, or will be, worse than expected. 

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

7

Table of contents

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

These factors are subjective and require consideration at each period end.

3)    Investment in Ambler Metals LLC

(a)

Formation of Ambler Metals LLC

On February 11, 2020, the Company completed the formation of a 50/50 joint venture named Ambler Metals LLC (“Ambler Metals”) with South32 Limited (“South32”). As part of the formation of the joint venture, Trilogy contributed all its assets associated with the UKMP, including the Arctic and Bornite Projects, while South32 contributed cash of $145 million, resulting in each party’s subsidiaries directly owning a 50% interest in Ambler Metals.

Ambler Metals is an independently operated company jointly controlled by Trilogy and South32 through a four-member board, of which two members are appointed by Trilogy based on its 50% equity interest. All significant decisions related to the UKMP require the approval of both companies. We determined that Ambler Metals is a VIE because it is expected to need additional funding from its owners for its significant activities. However, we concluded that we are not the primary beneficiary of Ambler Metals as the power to direct its activities, through its board, is shared under the Ambler Metals LLC limited liability company agreement. As we have significant influence over Ambler Metals through our representation on its board, we use the equity method of accounting for our investment in Ambler Metals. Our investment in Ambler Metals was initially measured at its fair value of $176 million upon recognition. Our maximum exposure to loss in this entity is limited to the carrying amount of our investment in Ambler Metals, which, as at August 31, 2023, totaled $136.9 million.

(b)

Carrying value of equity method investment

Trilogy recognized, based on its 50% ownership interest in Ambler Metals, an equity loss equivalent to its pro rata share of Ambler Metals’ comprehensive loss of $5.8 million for the three-month period ending August 31, 2023 (2022 - $17.9 million) and $12.0 million for the nine-month period ending August 31, 2023 (2022 - $26.6 million).  During the nine-month period ending August 31, 2023, Trilogy made a $111,000 equity contribution to Ambler Metals through the issuance of 143,505 common shares of the Company as part of the long-term incentive compensation for Ambler Metals executives. Likewise, South32 made an equivalent equity contribution to Ambler Metals for $111,000 in cash for their 50% share. The carrying value of Trilogy’s 50% investment in Ambler Metals as at August 31, 2023 is summarized on the following table.

    

in thousands of dollars

$

  

November 30, 2022, Investment in Ambler Metals

142,754

Joint venture equity contribution

111

Share of loss on equity investment for the nine-month period ending August 31, 2023

(5,998)

August 31, 2023, Investment in Ambler Metals

136,867

(c)

The following table summarizes Ambler Metals’ Balance Sheet as at August 31, 2023.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

8

Table of contents

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

    

in thousands of dollars

August 31, 2023

November 30, 2022

    

$

  

  

$

  

Total assets

102,140

114,049

Cash

66,866

80,755

Mineral properties

30,899

30,899

Total liabilities

(4,200)

(4,335)

Accounts payable and accrued liabilities

(3,707)

(3,664)

Members' equity (total assets less total liabilities)

97,940

109,714

Members’ cash is held at one bank, the majority of cash is uninsured as at August 31, 2023.

(d) The following table summarizes Ambler Metals' loss for the nine-month period ending August 31, 2023.

in thousands of dollars

Three months ended

Nine months ended

August 31, 2023

August 31, 2022

August 31, 2023

August 31, 2022

  

$

  

  

$

  

  

$

  

  

$

  

Depreciation

38

32

113

77

Corporate salaries and wages

478

477

1,417

1,437

General and administrative

43

158

389

560

Mineral property expense

5,210

17,120

10,002

24,527

Professional fees

181

125

397

626

Foreign exchange (gain)/loss

(6)

10

(3)

5

Interest and other income

(125)

(72)

(319)

(642)

Comprehensive loss

5,819

17,850

11,996

26,590

4)    Accounts payable and accrued liabilities

in thousands of dollars  

August 31, 2023

November 30, 2022

  

$

  

  

$

  

Trade accounts payable

92

188

Accrued liabilities

 

94

 

36

Accrued salaries and vacation

 

296

 

121

Accounts payable and accrued liabilities

 

482

 

345

Of the accrued salaries and vacation approximately $166,000 was settled, subsequent to the end of the third quarter, on September 1, 2023 through the issuance of common shares of the Company.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

9

Table of contents

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

5)    Leases

(a)Right-of-use asset

in thousands of dollars

  

$

  

Balance as at November 30, 2022

319

Net amortization

(131)

Balance as at August 31, 2023

188

(b)Lease liabilities

The Company’s lease arrangements primarily consist of an operating lease for our office space ending in June 2024. There are no extension options.

Total lease expense recorded within general and administrative expenses was comprised of the following components:

    

in thousands of dollars

Nine months ended

Nine months ended

August 31, 2023

August 31, 2022

$

  

  

$

  

Operating lease costs

140

140

Variable lease costs

103

108

Total lease expense

243

248

Variable lease costs consist primarily of the Company’s portion of operating costs associated with the office space lease as the Company elected to apply the practical expedient not to separate lease and non-lease components.

As at August 31, 2023, the weighted-average remaining lease term is 0.6 years and the weighted-average discount rate is 8%. Significant judgment was used in the determination of the incremental borrowing rate which included estimating the Company’s credit rating.

Supplemental cash and non-cash information relating to our leases during the nine-month period ending August 31, 2023 are as follows:

Cash paid for amounts included in the measurement of lease liabilities was $149,102.

Future minimum payments relating to the lease recognized in our balance sheet as of August 31, 2023 are as follows:

    

in thousands of dollars

August 31, 2023

 

Fiscal year

$

  

2023

 

51

2024

 

33

2025

 

Total undiscounted lease payments

 

84

Effect of discounting

 

(2)

Present value of lease payments recognized as lease liability

 

82

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

10

Table of contents

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

6)    Share capital

Authorized:

unlimited common shares, no par value

in thousands of dollars, except share amounts

Number of shares

Ascribed value

    

  

  

$

  

November 30, 2022

 

146,225,035

182,178

Private Placement, net of share issue cost

5,854,545

3,115

Restricted Share Units

2,807,921

1,780

Deferred Share Units

415,056

468

NovaGold deferred share units conversion

1,130

3

Services settled by common shares

112,142

60

Joint venture equity contribution (note 3(b))

143,505

111

August 31, 2023, issued and outstanding

155,559,334

187,715

On April 30, 2012, under the NovaGold Arrangement, Trilogy committed to issue common shares to satisfy holders of NovaGold deferred share units (“NovaGold DSUs”), once vested, on record as of the close of business April 27, 2012. When vested, Trilogy committed to deliver one common share to the holder for every six shares of NovaGold the holder is entitled to receive, rounded down to the nearest whole number. As at August 31, 2023, a total of 5,144 NovaGold DSUs remain outstanding representing a right to receive 859 Common Shares in Trilogy, which will settle upon certain directors retiring from NovaGold’s board.

(a)

Common shares issuance

On April 25, 2023, the Company completed a non-brokered private placement of 5,854,545 common shares of the Company (the “Common Share”) at a price of $0.55 per Common Share for gross proceeds of $3.2 million and net proceeds of $3.1 million.  Financing costs consisted of legal and stock exchange fees.

(b)

Stock options

During the three-month period ended February 28, 2023, the Company granted 3,230,000 stock options (2022 - 1,734,500 stock options) at an exercise price of CDN$0.78 (2022 - CDN$2.21) to employees, consultants and directors exercisable for a period of five years with various vesting terms from immediate vesting to vesting over a two-year period. The fair value attributable to this option grants was CDN$0.37 (2022 - CDN$0.94).   There were no stock options granted during the second and third quarters.

For the nine-month period ended August 31, 2023, Trilogy recognized a stock-based compensation charge of $0.8 million (2022 - $1.4 million) for options granted to directors, employees and service providers, net of estimated forfeitures.

The fair value of the stock options recognized in the period has been estimated using the Black-Scholes option pricing model.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

11

Table of contents

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

Assumptions used in the pricing model for the nine-month period ended August 31, 2023 are as provided below.

    

August 31, 2023

Risk-free interest rates

 

3.49%

Exercise price

 

CDN$0.78

Expected life

 

3 years

Expected volatility

 

67.7%

Expected dividends

 

Nil

As at August 31, 2023, there were 2,131,757 non-vested options outstanding with a weighted average exercise price of CDN$1.02; the non-vested stock option expense not yet recognized was $0.24 million. This expense is expected to be recognized over the next 16 months.

A summary of the Company’s stock option outstanding and changes during the nine-month period ended August 31, 2023 is as follows:

August 31, 2023

Weighted average

exercise price

    

Number of options

  

  

CDN$

  

Balance – beginning of the period

 

11,225,400

2.49

Granted

 

3,230,000

0.78

Cancelled

 

(286,000)

2.70

Expired

 

(1,170,000)

1.43

Balance – end of the period

 

12,999,400

2.16

There were no stock options exercised during the nine-month period ended August 31, 2023.

The following table summarizes information about the stock options outstanding at August 31, 2023.

Outstanding

Exercisable

Unvested

 

Weighted

Weighted

 

Number of

Weighted

average

Number of

average

Number of

 

outstanding

average years

exercise price

exercisable

exercise price

unvested

Range of exercise price - CDN

  

options

  

  

to expiry

  

  

CDN$

  

  

options

  

  

CDN$

  

  

options  

  

$0.75 to $1.00

 

3,230,000

4.27

0.78

1,463,328

0.78

1,766,672

$2.01 to $2.50

 

2,270,250

2.56

2.27

1,905,165

2.28

365,085

$2.51 to $3.00

6,041,650

1.73

2.64

6,041,650

2.64

$3.01 to $3.50

1,457,500

1.31

3.03

1,457,500

3.03

12,999,400

2.46

2.16

10,867,643

2.38

2,131,757

The aggregate intrinsic value of vested stock options (the market value less the exercise price) at August 31, 2023 was $Nil (2022 - $Nil) and the aggregate intrinsic value of exercised options for the nine-month period ending August 31, 2023 was $Nil (2022 - $0.05 million).

(c)

Restricted Share Units and Deferred Share Units

The Company has a Restricted Share Unit Plan (“RSU Plan”) to provide long-term incentives to employees and consultants and a Non-Executive Director Deferred Share Unit Plan (“DSU Plan”) to offset cash payments for fees to directors.  Awards under the RSU Plan and DSU Plan have been settled in common shares of the Company with each restricted share unit (“RSU”) and deferred share unit (“DSU”) entitling the holder to receive one common share of the Company.  All units are accounted for as equity-settled awards.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

12

Table of contents

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

A summary of the Company’s unit plans and changes during the nine-month period ending August 31, 2023 is as follows:

    

Number of RSUs

  

  

Number of DSUs

  

Balance – beginning of the period

257,268

 

1,560,734

Granted

 

4,273,433

1,107,895

Vested/Converted

 

(2,920,063)

(415,056)

Balance – end of the period

 

1,610,638

 

2,253,573

For the nine-month period ending August 31, 2023, Trilogy recognized a combined RSU and DSU stock-based compensation charge of $2.0 million (2022 - $1.6 million), net of estimated forfeitures.

7)    Financial instruments

The Company is exposed to a variety of risks arising from financial instruments. These risks and management’s objectives, policies and procedures for managing these risks are disclosed as follows.

The Company’s financial instruments consist of cash, accounts receivable, deposits, and accounts payable and accrued liabilities. The fair value of the Company’s financial instruments approximates their carrying value due to the short-term nature of their maturity. The Company’s financial instruments initially measured at fair value and then held at amortized cost include cash, accounts receivable, deposits, and accounts payable and accrued liabilities.

Financial risk management

The Company’s activities expose it to certain financial risks, including currency risk, credit risk, liquidity risk, interest risk and price risk.

(a)

Currency risk

Currency risk is the risk of a fluctuation in financial asset and liability settlement amounts due to a change in foreign exchange rates. The Company operates in the United States and Canada. The Company’s exposure to currency risk at August 31, 2023 is limited to the Canadian dollar balances consisting of cash of approximately CDN$126,000, accounts receivable of approximately CDN$12,000 and accounts payable of approximately CDN$340,000. Based on a 10% change in the US-Canadian exchange rate, assuming all other variables remain constant, the Company’s net loss would change by approximately $14,000.

(b)

Credit risk

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company holds cash with a Canadian chartered financial institution of which the majority is uninsured as at August 31, 2023. The Company’s only significant exposure to credit risk is equal to the balance of cash as recorded in the financial statements.

(c)

Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulties raising funds to meet its financial obligations as they fall due. The Company is in the exploration stage and does not have cash inflows from operations; therefore, the Company manages liquidity risk through the management of its capital structure and financial leverage.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

13

Table of contents

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

Contractually obligated undiscounted cash flow requirements as at August 31, 2023 are as follows:

in thousands of dollars

  

  

Total

  

  

< 1 Year

  

  

1–2 Years

  

  

2–5 Years

  

  

Thereafter

  

$

$

$

$

$

Accounts payable and accrued liabilities

 

482

 

482

 

Office lease

 

84

84

 

 

566

 

566

 

Included in accounts payable and accrued liabilities approximately $166,000 is for accrued salaries that were settled, subsequent to the end of the third quarter, on September 1, 2023 through the issuance of common shares of the Company (note 9).

(d)

Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk with respect to interest earned on cash. Based on balances as at August 31, 2023, a 1% change in interest rates would result in a negligible change in net loss, assuming all other variables remain constant.

As we are currently in the exploration phase none of our financial instruments are exposed to commodity price risk; however, our ability to obtain long-term financing and its economic viability could be affected by commodity price volatility.

8)    Commitment

The Company has commitments with respect to an office lease requiring future minimum lease payments as summarized in note 5(b) above.

9) Subsequent event

On September 1, 2023, pursuant to previous elections, the Board of Directors were granted 175,127 DSUs in settlement of approximately $82,750 of director fees and senior management were granted 283,693 RSUs in lieu of cash salaries of approximately $166,000, all vesting immediately. The grants were in support of an effort to preserve cash and increase share ownership by settling director fees and a portion of senior management salaries in shares of the Company.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

14

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Trilogy Metals Inc.

Management’s Discussion & Analysis

For the Quarter Ended August 31, 2023

(expressed in US dollars)

Cautionary notes

Forward-looking statements

This Management’s Discussion and Analysis contains “forward-looking information” and “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, Section 21E of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”), and other applicable securities laws. These forward-looking statements may include statements regarding the Company’s work programs and budgets, including statements about

the plans and budget for the 2023 field exploration program, perceived merit of properties, exploration results and budgets, the impact of the BLM’s suspension of permits on the right-of-way with the Alaska Industrial Development and Export Authority (“AIDEA”) relating to the Ambler Road Project, the Company and Ambler Metals’ funding requirements, mineral reserves and resource estimates, work programs, capital expenditures, operating costs, cash flow estimates, production estimates and similar statements relating to the economic viability of a project, timelines, strategic plans, statements regarding Ambler Metals’ plans and expectations relating to its Upper Kobuk Mineral Projects (as defined below), sufficiency of the $145 million subscription price to fund the UKMP, impact of COVID-19 on the Company’s operations, market prices for precious and base metals, statements regarding the Ambler Access Project (also known as the Ambler Mining District Industrial Access Project), or other statements that are not statements of fact. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Statements concerning mineral resource estimates may also be deemed to constitute “forward-looking statements” to the extent that they involve estimates of the mineralization that will be encountered if the property is developed.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, identified by words or phrases such as “expects”, “is expected”, “anticipates”, “believes”, “plans”, “projects”, “estimates”, “assumes”, “intends”, “strategy”, “goals”, “objectives”, “potential”, “possible” or variations thereof or stating that certain actions, events, conditions or results “may”, “could”, “would”, “should”, “might” or “will” be taken, occur or be achieved, or the negative of any of these terms and similar expressions) are not statements of historical fact and may be forward-looking statements.

Forward-looking statements are based on the beliefs, expectations and opinions of management on the date the statements are made, as well as on a number of material assumptions, which could prove to be significantly incorrect, including about:

our ability to achieve production at the Upper Kobuk Mineral Projects;
the accuracy of our mineral resource and reserve estimates;
the results, costs and timing of future exploration drilling and engineering;
timing and receipt of approvals, consents and permits under applicable legislation;
the adequacy of our financial resources;

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

15

the receipt of third party contractual, regulatory and governmental approvals for the exploration, development, construction and production of our properties and any litigation or challenges to such approvals;
our expected ability to develop adequate infrastructure and that the cost of doing so will be reasonable;
continued good relationships with South32, our joint venture partner, as well as local communities and other stakeholders;
there being no significant disruptions affecting operations, whether relating to labor, supply, power damage to equipment or other matter;
expected trends and specific assumptions regarding metal prices and currency exchange rates; and
prices for and availability of fuel, electricity, parts and equipment and other key supplies remaining consistent with current levels.

We have also assumed that no significant events will occur outside of our normal course of business. Although we have attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. We believe that the assumptions inherent in the forward-looking statements are reasonable as of the date of this MD&A. However, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to the inherent uncertainty therein.

Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors that could cause actual events or results to differ from those reflected in the forward-looking statements, including, without limitation:

risks related to the COVID-19 pandemic;
risks related to inability to define proven and probable reserves;
risks related to our ability to finance the development of our mineral properties through external financing, strategic alliances, the sale of property interests or otherwise;
uncertainty as to whether there will ever be production at the Company’s mineral exploration and development properties;
risks related to our ability to commence production and generate material revenues or obtain adequate financing for our planned exploration and development activities;
risks related to lack of infrastructure including but not limited to the risk whether or not the Ambler Mining District Industrial Access Project, or AMDIAP, will receive the requisite permits and, if it does, whether the Alaska Industrial Development and Export Authority will build the AMDIAP;
risks related to the suspension by the BLM of the right-of-way permits with AIDEA relating to the AMDIAP to permit the Department of the Interior to carry out additional work on the environmental impact statement, and associated delays relating to such suspension;
risks related to inclement weather which may delay or hinder exploration activities at our mineral properties;
risks related to our dependence on a third party for the development of our projects;

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

16

none of the Company’s mineral properties are in production or are under development;
commodity price fluctuations;
uncertainty related to title to our mineral properties;
our history of losses and expectation of future losses;
risks related to increases in demand for equipment, skilled labor and services needed for exploration and development of mineral properties, and related cost increases;
risks related to increases in costs of fuel and other required supplies and concerns relating to supply chain and the ability to obtain needed supplies at a reasonable cost, or at all;
risks related to global economic instability, including global supply chain issues, inflation and fuel and energy costs may affect the Company’s business;
uncertainties relating to the assumptions underlying our resource estimates, such as metal pricing, metallurgy, mineability, marketability and operating and capital costs;
uncertainty related to inferred mineral resources;
mining and development risks, including risks related to infrastructure, accidents, equipment breakdowns, labor disputes or other unanticipated difficulties with or interruptions in development, construction or production;
risks and uncertainties relating to the interpretation of drill results, the geology, grade and continuity of our mineral deposits;
risks related to governmental regulation and permits, including environmental regulation, including the risk that more stringent requirements or standards may be adopted or applied due to circumstances unrelated to the Company and outside of our control;
the risk that permits and governmental approvals necessary to develop and operate mines at our mineral properties will not be available on a timely basis or at all;
risks related to the need for reclamation activities on our properties and uncertainty of cost estimates related thereto;
risks related to the acquisition and integration of operations or projects;
our need to attract and retain qualified management and technical personnel;
risks related to conflicts of interests of some of our directors and officers;
risks related to potential future litigation;
risks related to market events and general economic conditions;
risks related to future sales or issuances of equity securities decreasing the value of existing Trilogy common shares, diluting voting power and reducing future earnings per share;
risks related to the voting power of our major shareholders and the impact that a sale by such shareholders may have on our share price;

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

17

uncertainty as to the volatility in the price of the Company’s common shares;
the Company’s expectation of not paying cash dividends;
adverse federal income tax consequences for U.S. shareholders should the Company be a passive foreign investment company;
risks related to global climate change;
risks related to adverse publicity from non-governmental organizations;
uncertainty as to our ability to maintain the adequacy of internal control over financial reporting as per the requirements of Section 404 of the Sarbanes-Oxley Act; and
increased regulatory compliance costs, associated with rules and regulations promulgated by the United States Securities and Exchange Commission, Canadian Securities Administrators, the NYSE American, the Toronto Stock Exchange, and the Financial Accounting Standards Boards, and more specifically, our efforts to comply with the Dodd-Frank Wall Street Reform and Consumer Protection Act.

This list is not exhaustive of the factors that may affect any of the Company’s forward-looking statements. Forward-looking statements are statements about the future and are inherently uncertain, and actual achievements of the Company or other future events or conditions may differ materially from those reflected in the forward-looking statements due to a variety of risks, uncertainties and other factors, including, without limitation, those referred to in Trilogy’s Form 10-K dated February 14, 2023, filed with the Canadian securities regulatory authorities and the SEC, and other information released by Trilogy and filed with the appropriate regulatory agencies.

The Company’s forward-looking statements are based on the beliefs, expectations and opinions of management on the date the statements are made, and the Company does not assume any obligation to update forward-looking statements if circumstances or management’s beliefs, expectations or opinions should change, except as required by law. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.

General

This Management’s Discussion and Analysis (“MD&A”) of Trilogy Metals Inc. (“Trilogy”, “Trilogy Metals”, “the Company” or “we”) is dated October 11, 2023 and provides an analysis of our unaudited interim financial results for the quarter ended August 31, 2023 compared to the quarter ended August 31, 2022.

The following information should be read in conjunction with our August 31, 2023 unaudited interim condensed consolidated financial statements and related notes which were prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”). The MD&A should also be read in conjunction with our audited consolidated financial statements and related notes for the year ended November 30, 2022. A summary of the U.S. GAAP accounting policies is outlined in note 2 of the audited consolidated financial statements. All amounts are in United States dollars unless otherwise stated. References to “Canadian dollars” and “CDN$” are to the currency of Canada and references to “U.S. dollars”, “$” or “US$” are to the currency of the United States.

Richard Gosse, P.Geo., Vice President, Exploration of the Company, is a Qualified Person under National Instrument 43-101 - Standards of Disclosure for Mineral Projects (“NI 43-101”), and has approved the scientific and technical information in this MD&A.

Trilogy’s shares are listed on the Toronto Stock Exchange (“TSX”) and the NYSE American Stock Exchange (“NYSE American”) under the symbol “TMQ”. Additional information related to Trilogy, including our annual report on Form 10-K, is available on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

18

Description of business

We are a base metals exploration company focused on the exploration and development of mineral properties, through our equity investee, in the Ambler mining district located in Alaska, U.S.A. We conduct our operations through a wholly owned subsidiary, NovaCopper US Inc. which is doing business as Trilogy Metals US (“Trilogy Metals US”). Our Upper Kobuk Mineral Projects, (“UKMP” or “UKMP Projects”) were contributed into a 50/50 joint venture named Ambler Metals LLC (“Ambler Metals”) between Trilogy and South32 Limited (“South32”) on February 11, 2020 (see below). The projects contributed to Ambler Metals consist of: i) the Ambler lands which host the Arctic copper-zinc-lead-gold-silver project (the “Arctic Project”); and ii) the Bornite lands being explored under a collaborative long-term agreement with NANA Regional Corporation, Inc. (“NANA”), a regional Alaska Native Corporation, which hosts the Bornite carbonate-hosted copper project (the “Bornite Project”) and related assets. The Company may also conduct early-stage exploration through a wholly owned subsidiary, 995 Exploration Inc.

Project activities

UKMP Field Activities

In July, Ambler Metals used the camp to support a small team of geologists who were continuing work started in 2022 on the stratigraphy and alteration of the Arctic deposit. The focus of the work was to relog existing drill core from 13 holes across the deposit and 4 holes from regional prospects. In addition, sampling was undertaken for chemostratigraphy and alteration footprint definition. Geological and talc models for the Arctic deposit were updated and an updated geological and structural model for the area surrounding Arctic was recommended.

The camp was also utilized by Ambler Metals to conduct sampling of core from the Bornite deposit to be used in a study initiated by the Center to Advance the Science of Exploration to Reclamation in Mining (“CASERM”) at the Colorado School of Mines to investigate the occurrence and distribution of critical elements, including germanium.  Ambler Metals has recently accepted a proposal from CASERM with leveraged funding from the United States Geological Survey to contribute samples from Bornite to further investigate the occurrence, distribution, and sequestration of critical elements, including germanium, using a suite of micro-analytical methods such as SEM- and XRF-based techniques, electron probe micro analysis, and LA-ICP-MS. Objectives of the study include compiling a comprehensive whole-rock 60+ geochemical dataset of select samples from the Bornite deposit that complement the existing dataset from the South Reef area related to a recently prepared Master of Science thesis.

Bornite Studies

Ambler Metals has engaged Wood Canada Limited and SRK Consulting (Canada) Inc. to complete an initial scoping level study on the Bornite deposit to determine if the ore at Bornite may extend the mine life at the proposed Arctic Project. The scope of work covers mining, processing, hydrogeology, infrastructure, tailings management, and waste rock management.

The study assumes that ore from Bornite will be transported approximately 30 km northeast to the Arctic mill for processing after completion of mining at the Arctic deposit. Bornite will utilize the proposed infrastructure supporting the Arctic Project including power generation, airstrips and camp. There are potential significant synergies between  Arctic and Bornite which could lower the overall capital costs and extend the regional mine life from 13 years for the Arctic deposit to 30 years with both Arctic and Bornite.

The study is considering both an open-pit and an underground mine using existing geologic modelling, geotechnical information, and hydrogeological information and, where possible, will rely on concepts and costs developed for the Arctic Feasibility Study.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

19

Metallurgical test work to potentially increase cobalt reporting with copper concentrate was initiated in July using three previously tested concentrates from the Bornite deposit. The test work is being conducted by ALS Minerals and is expected to be completed in the fourth quarter of this year.

Ambler Mining District Industrial Access Project (“AMDIAP” or “Ambler Access Project”)  

AIDEA started field work in May 2023 utilizing a camp at Coldfoot, which work was completed in mid-September. In mid-June AIDEA started utilizing the Ambler Metals Bornite camp with an average of 40 people daily at camp throughout the summer with approximately 20 NANA shareholder hires among them. Ambler Metals recently closed the Bornite camp with no safety incidents reported.  AIDEA successfully completed the planned field program from Bornite consisting of cultural resource inventory surveys and testing of sites over approximately 450 acres, hydraulic and hydrology studies at bridge crossings to assess conditions for area drainage, culvert placement and bridge design, collecting topographical and bathymetric survey data to support bridge data and fish passage culverts, engineering reconnaissance surveys and fish habitat investigations.  In March 2023, the board of Ambler Metals approved funding of $12.3 million, a 50% share of the total budget of $24.6 million for the Ambler Access Project which is being funded equally by AIDEA and Ambler Metals.  As at August 31, 2023, $6.5 million has been spent to date on logistics and cost of the field season.

On November 15, 2022, the United States Bureau of Land Management (“USBLM”) submitted a status report announcing that it anticipated publishing a draft Supplemental Environmental Impact Statement (“SEIS”) in the second quarter of calendar 2023 and a final SEIS in the fourth quarter of calendar 2023. On January 17, 2023 and March 20, 2023, the USBLM submitted status reports reaffirming the timing of the draft and final SEIS.

On May 19, 2023, the USBLM submitted a status report revising the timeline for development of the SEIS and a subsequent Record of Decision. The USBLM now anticipates publishing a draft SEIS in the third quarter of calendar year 2023, a final SEIS in the first quarter of calendar year 2024, and a Record of Decision within the second quarter of calendar year 2024.   On July 18, 2023 and September 18, 2023, the USBLM submitted status reports reaffirming the timing of the draft SEIS, final SEIS and the Record of Decision.

Corporate developments

Private Placement

On April 25, 2023, the Company completed non-brokered private placement of 5,854,545 common shares of the Company (the “Common Share”) at a price of $0.55 per Common Share for gross proceeds of $3.2 million.  After legal and stock exchange fees, the Company received net proceeds of $3.1 million.

Annual General Meeting

The Annual General Meeting of shareholders was held on May 17, 2023.  All directors nominated by the Company and standing for election were elected by shareholders of the Company, with each director receiving greater than 97% of the votes cast.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

20

Summary of results

in thousands of US dollars, except per share amounts

Three months ended

Nine months ended

August 31, 2023

August 31, 2022

August 31, 2023

August 31, 2022

Selected expenses

  

$

  

$

  

$

  

$

  

General and administrative

278

279

1,014

1,014

Investor relations

18

18

71

155

Professional fees

139

131

897

568

Salaries

191

172

621

847

Salaries and directors expense – stock-based compensation

526

562

3,379

3,146

Share of loss on equity investment

2,910

8,925

5,998

13,295

Comprehensive loss for the period

(4,052)

(9,938)

(11,927)

(19,035)

Basic and diluted loss per common share

(0.03)

(0.07)

(0.08)

(0.13)

For the three-month period ended August 31, 2023, we reported a net loss of $4.1 million compared to a net loss of $9.9 million for the three-month period ended August 31, 2022. The decrease in comprehensive loss in the third quarter of 2023 compared to the same quarter in 2022 is due to the decrease in our share of loss of Ambler Metals, and stock-based compensation and salaries. The decrease of our share of losses of Ambler Metals is mainly due to the decrease in mineral property expenses over the comparative quarter in the prior year from the decrease in drilling, engineering and project support costs and partially offset from the increased cost in the Ambler Access Project.

For the nine-month period ended August 31, 2023, we reported a net loss of $11.9 million compared to a net loss of $19.0 million for the nine-month period ended August 31, 2022. The difference for the nine-month period ended August 31, 2023, when compared to the same period in 2022, is primarily due to a $7.3 million decrease in our equity pick-up of Ambler Metals’ comprehensive loss in the current period as well as decreases in salaries and investor relations, and partially offset from the increase in professional fees and stock-based compensation.  The decrease in our share of losses of Ambler Metals is mainly due to the decrease in mineral property expenses over the comparable period in the prior year from decreases in drilling, engineering, and project support costs and partially offset from the increase in the Ambler Access Project cost.

Liquidity and capital resources

We expended $2.6 million on operating activities during the nine-month period ending August 31, 2023 with the majority of cash spent on corporate salaries, professional fees related to our annual regulatory filings, and annual fees paid to the Toronto Stock Exchange and the NYSE American Exchange with the American and Canadian securities commissions.  

As at August 31, 2023, we had cash and working capital of $3.0 million. Management continues with cash preservation strategies to reduce cash expenditures where feasible, including but not limited to reductions in marketing and investor conferences and office expenses.  In addition, the Company’s Board of Directors have agreed to take all of their fees in deferred share units in an effort to preserve cash.  The Company’s senior management team is also taking a portion of their base salaries in shares of the Company to preserve cash.

All project related costs are funded by Ambler Metals. Amber Metals is well funded to advance the UKMP with $66.9 million in cash and $66.0 million in working capital as at August 31, 2023. There are sufficient funds at Ambler Metals to fund this fiscal year’s budget for the UKMP and the Ambler Access Project. Trilogy does not anticipate having to fund the activities of Ambler Metals until the current cash balance of $66.9 million is expended.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

21

Off-balance sheet arrangements

We have no material off-balance sheet arrangements.

Outstanding share data

As at October 11, 2023, we had 155,883,843 common shares issued and outstanding. As at October 11, 2023, we had 12,999,400 stock options outstanding with a weighted-average exercise price of CDN$2.16, 2,428,701 Deferred Share Units (“DSUs”), and 1,610,638 Restricted Share Units (“RSUs”) outstanding. As at October 11, 2023 we hold 5,144 NovaGold Resources Inc. (“NovaGold”) DSUs for which the NovaGold director is entitled to receive one common share of Trilogy for every six NovaGold shares to be received upon their retirement from the NovaGold board.  A total of 859 common shares will be issued upon redemption of the NovaGold DSUs. Upon the exercise of all the foregoing convertible securities, the Company would be required to issue an aggregate of 17,039,598 common shares.

New accounting pronouncements

There are no new accounting pronouncements affecting the Company.

Critical accounting estimates

The most critical accounting estimates upon which our financial status depends are those requiring estimates of the recoverability of our equity method investment in Ambler Metals, income taxes and valuation of stock‐based compensation.

Impairment of Investment in Ambler Metals LLC

Management assesses the possibility of impairment in the carrying value of its equity method investment in Ambler Metals whenever events or circumstances indicate that the carrying amount of the investment may not be recoverable. Significant judgments are made in assessing the possibility of impairment. Factors that may be indicative of an impairment include a loss in the value of an investment that is not temporary. Management considers several factors in considering if an indicator of impairment has occurred, including but not limited to, sustained losses by the investment, the absence of the ability to recover the carrying amount of the investment, significant changes in the legal, business or regulatory environment, significant adverse changes impacting the investee including the status of the Ambler Access  Project and internal reporting indicating the economic performance of an investment is, or will be, worse than expected.

These factors are subjective and require consideration at each period end. If an indicator of impairment is determined to exist, the fair value of the impaired investment is determined based on the valuation of cohort companies with similar projects or upon the present value of expected future cash flows using discount rates and other assumptions believed to be consistent with those used by principal market participants and observed market earnings multiples of comparable companies.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

22

Management calculates the estimated undiscounted future net cash flows relating to the asset or asset group using estimated future prices, proven and probable reserves and other mineral resources, and operating, capital and reclamation costs. When the carrying value of an asset exceeds the related undiscounted cash flows, the asset is written down to its estimated fair value, which is usually determined using discounted future cash flows. Management’s estimates of mineral prices, mineral resources, foreign exchange rates, production levels operating, capital and reclamation costs are subject to risk and uncertainties that may affect the determination of the recoverability of the long-lived asset. It is possible that material changes could occur that may adversely affect management’s estimates.

Income taxes

We must make estimates and judgments in determining the provision for income tax expense, deferred tax assets and liabilities, and liabilities for unrecognized tax benefits including interest and penalties. We are subject to income tax law in the United States and Canada. The evaluation of tax liabilities involving uncertainties in the application of complex tax regulation is based on factors such as changes in facts or circumstances, changes in tax law, new audit activity, and effectively settled issues. The evaluation of an uncertain tax position requires significant judgment, and a change in such recognition would result in an additional charge to the income tax expense and liability.

Stock-based compensation

Compensation expense for options granted to employees, directors and certain service providers is determined based on estimated fair values of the options at the time of grant using the Black-Scholes option pricing model, which takes into account, as of the grant date, the fair market value of the shares, expected volatility, expected life, expected forfeiture rate, expected dividend yield and the risk-free interest rate over the expected life of the option. The use of the Black-Scholes option pricing model requires input estimation of the expected life of the option, volatility, and forfeiture rate which can have a significant impact on the valuation model, and resulting expense recorded.

Additional information

Additional information regarding the Company, including our annual report on Form 10-K, is available on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov and on our website at www.trilogymetals.com. Information contained on our website is not incorporated by reference.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not applicable.

Item 4. Controls and Procedures

Disclosure controls and procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed in reports filed or submitted by the Company under U.S. and Canadian securities legislation is recorded, processed, summarized and reported within the time periods specified in those rules, including providing reasonable assurance that material information is gathered and reported to senior management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to permit timely decisions regarding public disclosure. Management, including the CEO and CFO, has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures, as defined in Rule 13a-15(e) and 15d-15(e) of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules of Canadian Securities Administration, as of August 31, 2023. Based on this evaluation, the CEO and CFO have concluded that the Company’s disclosure controls and procedures were effective.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

23

Internal control over financial reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act and National Instrument 52-109 Certification of Disclosure in Issuer’s Annual and Interim filings. Any system of internal control over financial reporting, no matter how well designed, has inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

Changes in internal control over financial reporting

There have been no changes in our internal controls over financial reporting during the fiscal quarter ended August 31, 2023 which have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting. We continue to evaluate our internal control over financial reporting on an ongoing basis to identify improvements.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we are a party to routine litigation and proceedings that are considered part of the ordinary course of its business. We are not aware of any material current, pending, or threatened litigation.

Item 1A. Risk Factors

Trilogy and its future business, operations and financial condition are subject to various risks and uncertainties due to the nature of its business and the present stage of exploration of its mineral properties. Certain of these risks and uncertainties are under the heading “Risk Factors” under Trilogy’s Form 10-K dated February 14, 2023 (“Form 10-K”) which is available on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov and on our website at www.trilogymetals.com.  There have been no material changes to the risk factors set forth in Trilogy’s Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

These disclosures are not applicable to us.

Item 5. Other Information

None.

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

24

Item 6. Exhibits

Exhibit No.

    

Description

3.1

Certificate of Incorporation, dated April 27, 2011 (incorporated by reference Exhibit 99.2 to the Registration Statement on Form 40-F as filed on March 1, 2012, File No. 001-35447)

3.2

Articles of Trilogy Metals Inc., effective April 27, 2011, as altered March 20, 2011 (incorporated by reference to Exhibit 99.3 to Amendment No. 1 to the Registration Statement on Form 40-F as filed on April 19, 2012, File No. 001-35447)

3.3

Notice of Articles and Certificate of Change of Name, dated September 1, 2016 (incorporated by reference to Exhibit 3.1 to the Form 8-K dated September 8, 2016)

31.1

Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) 

31.2

Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) 

32.1

Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350

32.2

Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350

101

Interactive Data Files

101.INS

Inline XBRL Instance Document

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File – the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

25

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: October 11, 2023

TRILOGY METALS INC.

By:   

/s/ Tony Giardini

Tony Giardini

President and Chief Executive Officer

By:   

/s/ Elaine M. Sanders

Elaine M. Sanders

Vice President and Chief Financial Officer

Trilogy Metals Inc.
For the Quarter Ended August 31, 2023

26

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULE 13a-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Tony Giardini, certify that:

1)I have reviewed this Quarterly Report on Form 10-Q of Trilogy Metals Inc.

2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5)The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:      October 11, 2023

By:

/s/ Tony Giardini

Tony Giardini

President and Chief Executive Officer

(principal executive officer)



Exhibit 31.2

CERTIFICATION PURSUANT TO

RULE 13a-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Elaine Sanders, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Trilogy Metals Inc.

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:    October 11, 2023

By:

/s/ Elaine Sanders

Elaine Sanders

Vice President and Chief Financial Officer

(principal financial officer)



Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Trilogy Metals Inc. (the “Registrant”) for the period ended August 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Tony Giardini, President and Chief Executive Officer of the Registrant, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:

October 11, 2023

By:

/s/ Tony Giardini

 

 

Tony Giardini

 

 

President and Chief Executive Officer

 

 

(principal executive officer)

 


Exhibit 32.2

 

 

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Trilogy Metals Inc. (the “Registrant”) for the period ended August 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Elaine Sanders, Vice President and Chief Financial Officer of the Registrant, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:

October 11, 2023

 

By:

/s/ Elaine Sanders

 

 

Elaine Sanders

 

 

Vice President and Chief Financial Officer

 

 

(principal financial officer)

 


v3.23.3
Document and Entity Information - shares
9 Months Ended
Aug. 31, 2023
Oct. 11, 2023
Document and Entity Information    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Aug. 31, 2023  
Document Transition Report false  
Entity File Number 1-35447  
Entity Registrant Name TRILOGY METALS INC.  
Entity Incorporation, State or Country Code A1  
Entity Tax Identification Number 98-1006991  
Entity Address, Address Line One Suite 1150, 609 Granville Street  
Entity Address, City or Town Vancouver  
Entity Address, State or Province BC  
Entity Address, Country CA  
Entity Address, Postal Zip Code V7Y 1G5  
City Area Code 604  
Local Phone Number 638-8088  
Title of 12(b) Security Common Shares  
Trading Symbol TMQ  
Security Exchange Name NYSEAMER  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   155,883,843
Current Fiscal Year End Date --11-30  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Entity Central Index Key 0001543418  
Amendment Flag false  
v3.23.3
Interim Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Aug. 31, 2023
Nov. 30, 2022
Current assets    
Cash $ 3,049 $ 2,573
Accounts receivable 10 17
Deposits and prepaid amounts 457 320
Total current assets 3,516 2,910
Investment in Ambler Metals LLC (note 3) 136,867 142,754
Fixed assets 6 12
Right of use asset (note 5 (a)) 188 319
Total assets 140,577 145,995
Current liabilities    
Accounts payable and accrued liabilities (note 4) 482 345
Current portion of lease liability 82 189
Total current liabilities 564 534
Long-term portion of lease liability   33
Total liabilities 564 567
Shareholders' equity    
Share capital (note 6) - unlimited common shares authorized, no par value issued - 155,559,334 (2022 - 145,868,502) 187,715 182,178
Contributed surplus 118 122
Contributed surplus - options (note 6(b)) 28,111 27,352
Contributed surplus - units (note 6(c)) 2,858 2,638
Deficit (78,789) (66,862)
Total shareholders' equity 140,013 145,428
Total liabilities and shareholders' equity $ 140,577 $ 145,995
v3.23.3
Interim Consolidated Balance Sheets (Parenthetical) - $ / shares
9 Months Ended 12 Months Ended
Aug. 31, 2023
Nov. 30, 2022
Interim Consolidated Balance Sheets (unaudited)    
Unlimited common shares authorized Unlimited Unlimited
Common Stock, No Par Value $ 0 $ 0
Common Stock, Shares, Issued 155,559,334 145,868,502
v3.23.3
Interim Consolidated Statements of Loss and Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 31, 2023
Aug. 31, 2022
Aug. 31, 2023
Aug. 31, 2022
Expenses        
Amortization $ 2 $ 4 $ 6 $ 15
Exploration expenses 22 11 23 11
Foreign exchange (gain) loss 3 (11) 1 (7)
General and administrative 278 279 1,014 1,014
Investor relations 18 18 71 155
Professional fees 139 131 897 568
Salaries 191 172 621 847
Salaries and directors expense - stock-based compensation 526 562 3,379 3,146
Total expenses 1,179 1,166 6,012 5,749
Other items        
Gain on disposition of mineral property   (84)   (84)
Interest and other income (37) (11) (83) (15)
Share of loss on equity investment (note 3(b)) 2,910 8,925 5,998 13,295
Write off mineral properties   (58)   90
Loss and comprehensive loss for the period $ (4,052) $ (9,938) $ (11,927) $ (19,035)
Basic loss per common share $ (0.03) $ (0.07) $ (0.08) $ (0.13)
Diluted loss per common share $ (0.03) $ (0.07) $ (0.08) $ (0.13)
Basic weighted average number of common shares outstanding 155,550,284 145,865,847 151,572,299 145,555,376
Diluted weighted average number of common shares outstanding 155,550,284 145,865,847 151,572,299 145,555,376
v3.23.3
Interim Consolidated Statements of Changes in Shareholders' Equity (unaudited) - USD ($)
$ in Thousands
Share capital
Contributed surplus.
Contributed surplus - options
Contributed surplus - units.
Deficit
Total
Beginning Balance at Nov. 30, 2021 $ 180,820 $ 122 $ 25,990 $ 1,712 $ (42,605) $ 166,039
Beginning Balance (Shares) at Nov. 30, 2021 145,009,811          
Exercise of options $ 50   (32)     18
Exercise of options (Shares) 31,674          
Restricted Share Units $ 650     (650)    
Restricted Share Units (Shares) 391,332          
Joint venture contribution $ 51         51
Joint venture contribution (Shares) 31,469          
Stock-based compensation     864 1,001   1,865
Loss for the period         (5,023) (5,023)
Ending Balance at Feb. 28, 2022 $ 181,571 122 26,822 2,063 (47,628) 162,950
Ending Balance (Shares) at Feb. 28, 2022 145,464,286          
Beginning Balance at Nov. 30, 2021 $ 180,820 122 25,990 1,712 (42,605) 166,039
Beginning Balance (Shares) at Nov. 30, 2021 145,009,811          
Loss for the period           (19,035)
Ending Balance at Aug. 31, 2022 $ 181,945 122 27,327 2,294 (61,640) 150,048
Ending Balance (Shares) at Aug. 31, 2022 145,868,502          
Beginning Balance at Feb. 28, 2022 $ 181,571 122 26,822 2,063 (47,628) 162,950
Beginning Balance (Shares) at Feb. 28, 2022 145,464,286          
Exercise of options $ 26   10     36
Exercise of options (Shares) 50,000          
Restricted Share Units $ 113     (113)    
Restricted Share Units (Shares) 110,000          
Stock-based compensation     274 229   503
Loss for the period         (4,074) (4,074)
Ending Balance at May. 31, 2022 $ 181,710 122 27,106 2,179 (51,702) 159,415
Ending Balance (Shares) at May. 31, 2022 145,624,286          
Restricted Share Units $ 235     (235)    
Restricted Share Units (Shares) 244,216          
Stock-based compensation     221 350   571
Loss for the period         (9,938) (9,938)
Ending Balance at Aug. 31, 2022 $ 181,945 122 27,327 2,294 (61,640) 150,048
Ending Balance (Shares) at Aug. 31, 2022 145,868,502          
Beginning Balance at Nov. 30, 2022 $ 182,178 122 27,352 2,638 (66,862) 145,428
Beginning Balance (Shares) at Nov. 30, 2022 146,225,035          
Restricted Share Units $ 1,538 (1)   (1,537)    
Restricted Share Units (Shares) 2,346,366          
Joint venture contribution $ 111         111
Joint venture contribution (Shares) 143,505          
Services settled by common shares $ 4         4
Services settled by common shares (in shares) 7,793          
Stock-based compensation     520 1,700   2,220
Loss for the period         (5,072) (5,072)
Ending Balance at Feb. 28, 2023 $ 183,831 121 27,872 2,801 (71,934) 142,691
Ending Balance (Shares) at Feb. 28, 2023 148,722,699          
Beginning Balance at Nov. 30, 2022 $ 182,178 122 27,352 2,638 (66,862) 145,428
Beginning Balance (Shares) at Nov. 30, 2022 146,225,035          
Shares issued for private placement, net of share issue cost $ 3,115          
Shares issued for private placement, net of share issue cost (Shares) 5,854,545          
Restricted Share Units (Shares) 2,807,921          
Joint venture contribution (Shares) 143,505          
Services settled by common shares $ 60          
Services settled by common shares (in shares) 112,142          
NovaGold deferred share units conversion $ 3          
NovaGold deferred share units conversion (Shares) 1,130          
Loss for the period           (11,927)
Ending Balance at Aug. 31, 2023 $ 187,715 118 28,111 2,858 (78,789) 140,013
Ending Balance (Shares) at Aug. 31, 2023 155,559,334          
Beginning Balance at Feb. 28, 2023 $ 183,831 121 27,872 2,801 (71,934) 142,691
Beginning Balance (Shares) at Feb. 28, 2023 148,722,699          
Shares issued for private placement, net of share issue cost $ 3,115         3,115
Shares issued for private placement, net of share issue cost (Shares) 5,854,545          
Restricted Share Units $ 121         121
Restricted Share Units (Shares) 213,463          
Deferred share units $ 468     (468)    
Deferred share units (Shares) 415,056          
Services settled by common shares $ 35         35
Services settled by common shares (in shares) 63,533          
Stock-based compensation     114 257   371
Loss for the period         (2,803) (2,803)
Ending Balance at May. 31, 2023 $ 187,570 121 27,986 2,590 (74,737) 143,530
Ending Balance (Shares) at May. 31, 2023 155,269,296          
Restricted Share Units $ 122         122
Restricted Share Units (Shares) 248,092          
Services settled by common shares $ 20         20
Services settled by common shares (in shares) 40,816          
Stock-based compensation     125 268   393
NovaGold deferred share units conversion $ 3 (3)        
NovaGold deferred share units conversion (Shares) 1,130          
Loss for the period         (4,052) (4,052)
Ending Balance at Aug. 31, 2023 $ 187,715 $ 118 $ 28,111 $ 2,858 $ (78,789) $ 140,013
Ending Balance (Shares) at Aug. 31, 2023 155,559,334          
v3.23.3
Interim Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 31, 2022
Aug. 31, 2023
Aug. 31, 2022
Cash flows used in operating activities      
Loss for the period $ (9,938) $ (11,927) $ (19,035)
Adjustments to reconcile net loss to cash flows in operating activities      
Amortization   6 15
Professional fees settled by common shares   86  
Office lease accounting   (9) (13)
Gain on disposal of mineral property (84)   (84)
Loss on equity investment in Ambler Metals LLC (note 3(b)) 8,925 5,998 13,295
Unrealized foreign exchange loss   5 (1)
Stock-based compensation   3,379 2,939
Write off mineral properties     90
Net change in non-cash working capital      
Decrease in accounts receivable   7 8
Increase in deposits and prepaid amounts   (137) (231)
Decrease in accounts payable and accrued liabilities   (42) (350)
Total cash flows used in operating activities   (2,634) (3,367)
Cash flows from financing activities      
Issuance of common shares, net of share issue cost (note 6(a))   3,115  
Proceeds from exercise of options     54
Total cash flows from financing activities   3,115 54
Cash flows from investing activities      
Proceeds from disposition of mineral property     142
Total cash flows from investing activities     142
Increase (decrease) in cash   481 (3,171)
Effect of exchange rate on cash   (5) (4)
Cash - beginning of the period   2,573 6,308
Cash - end of the period $ 3,133 $ 3,049 $ 3,133
v3.23.3
Nature of operations
9 Months Ended
Aug. 31, 2023
Nature of operations  
Nature of operations

1)    Nature of operations

Trilogy Metals Inc. (“Trilogy” or the “Company”) was incorporated in British Columbia under the Business Corporations Act (British Columbia) on April 27, 2011. The Company is engaged in the exploration and development of mineral properties, through our equity investee (see note 3), with a focus on the Upper Kobuk Mineral Projects (“UKMP”), including the Arctic and Bornite Projects located in Northwest Alaska in the United States of America (“US”). The Company also conducts early-stage exploration through a wholly owned subsidiary, 995 Exploration Inc.  

v3.23.3
Summary of significant accounting policies
9 Months Ended
Aug. 31, 2023
Summary of significant accounting policies  
Summary of significant accounting policies

2)    Summary of significant accounting policies

Basis of presentation

These interim consolidated financial statements have been prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Trilogy and its wholly owned subsidiaries, NovaCopper US Inc. (dba “Trilogy Metals US”) and 995 Exploration Inc. All intercompany transactions are eliminated on consolidation. For variable interest entities (“VIEs”) where Trilogy is not the primary beneficiary, we use the equity method of accounting.

All figures are in United States dollars unless otherwise noted. References to CDN$ refer to amounts in Canadian dollars.

These interim consolidated financial statements include all adjustments necessary for the fair presentation of the Company’s financial position as of August 31, 2023 and our results of operations and cash flows for the nine-month period ended August 31, 2023 and August 31, 2022. The results of operations for the nine-month period ended August 31, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending November 30, 2023.

As these interim consolidated financial statements do not contain all of the disclosures required by U.S. GAAP for annual financial statements, these interim consolidated financial statements should be read in conjunction with the annual financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended November 30, 2022, filed with the U.S. Securities and Exchange Commission (“SEC”) and Canadian securities regulatory authorities on February 14, 2023.

These interim consolidated financial statements were approved by the Company’s Audit Committee on behalf of the Board of Directors for issue on October 10, 2023.

Use of estimates and measurement uncertainties

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions of future events that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of expenditures during the period. Significant judgments include the assessment of potential indicators of impairment for our equity method investments where key judgement is the delay on the Ambler Access Project is temporary and the delay was considered when assessing indicators of impairment. Significant estimates include the measurement of income taxes, and the valuation of stock-based compensation. Actual results could differ materially from those reported.

Management assesses the possibility of impairment in the carrying value of its equity method investment in Ambler Metals whenever events or circumstances indicate that the carrying amount of the investment may not be recoverable. Significant judgments are made in assessing the possibility of impairment. Factors that may be indicative of an impairment include a loss in the value of an investment that is not temporary. Management considers several factors in considering if an indicator of impairment has occurred, including but not limited to, sustained losses by the investment, the absence of the ability to recover the carrying amount of the investment, significant changes in the legal, business or regulatory environment, significant adverse changes impacting the investee and internal reporting indicating the economic performance of an investment is, or will be, worse than expected. 

These factors are subjective and require consideration at each period end.

v3.23.3
Investment in Ambler Metals LLC
9 Months Ended
Aug. 31, 2023
Investment in Ambler Metals LLC  
Investment in Ambler Metals LLC

3)    Investment in Ambler Metals LLC

(a)

Formation of Ambler Metals LLC

On February 11, 2020, the Company completed the formation of a 50/50 joint venture named Ambler Metals LLC (“Ambler Metals”) with South32 Limited (“South32”). As part of the formation of the joint venture, Trilogy contributed all its assets associated with the UKMP, including the Arctic and Bornite Projects, while South32 contributed cash of $145 million, resulting in each party’s subsidiaries directly owning a 50% interest in Ambler Metals.

Ambler Metals is an independently operated company jointly controlled by Trilogy and South32 through a four-member board, of which two members are appointed by Trilogy based on its 50% equity interest. All significant decisions related to the UKMP require the approval of both companies. We determined that Ambler Metals is a VIE because it is expected to need additional funding from its owners for its significant activities. However, we concluded that we are not the primary beneficiary of Ambler Metals as the power to direct its activities, through its board, is shared under the Ambler Metals LLC limited liability company agreement. As we have significant influence over Ambler Metals through our representation on its board, we use the equity method of accounting for our investment in Ambler Metals. Our investment in Ambler Metals was initially measured at its fair value of $176 million upon recognition. Our maximum exposure to loss in this entity is limited to the carrying amount of our investment in Ambler Metals, which, as at August 31, 2023, totaled $136.9 million.

(b)

Carrying value of equity method investment

Trilogy recognized, based on its 50% ownership interest in Ambler Metals, an equity loss equivalent to its pro rata share of Ambler Metals’ comprehensive loss of $5.8 million for the three-month period ending August 31, 2023 (2022 - $17.9 million) and $12.0 million for the nine-month period ending August 31, 2023 (2022 - $26.6 million).  During the nine-month period ending August 31, 2023, Trilogy made a $111,000 equity contribution to Ambler Metals through the issuance of 143,505 common shares of the Company as part of the long-term incentive compensation for Ambler Metals executives. Likewise, South32 made an equivalent equity contribution to Ambler Metals for $111,000 in cash for their 50% share. The carrying value of Trilogy’s 50% investment in Ambler Metals as at August 31, 2023 is summarized on the following table.

    

in thousands of dollars

$

  

November 30, 2022, Investment in Ambler Metals

142,754

Joint venture equity contribution

111

Share of loss on equity investment for the nine-month period ending August 31, 2023

(5,998)

August 31, 2023, Investment in Ambler Metals

136,867

(c)

The following table summarizes Ambler Metals’ Balance Sheet as at August 31, 2023.

    

in thousands of dollars

August 31, 2023

November 30, 2022

    

$

  

  

$

  

Total assets

102,140

114,049

Cash

66,866

80,755

Mineral properties

30,899

30,899

Total liabilities

(4,200)

(4,335)

Accounts payable and accrued liabilities

(3,707)

(3,664)

Members' equity (total assets less total liabilities)

97,940

109,714

Members’ cash is held at one bank, the majority of cash is uninsured as at August 31, 2023.

(d) The following table summarizes Ambler Metals' loss for the nine-month period ending August 31, 2023.

in thousands of dollars

Three months ended

Nine months ended

August 31, 2023

August 31, 2022

August 31, 2023

August 31, 2022

  

$

  

  

$

  

  

$

  

  

$

  

Depreciation

38

32

113

77

Corporate salaries and wages

478

477

1,417

1,437

General and administrative

43

158

389

560

Mineral property expense

5,210

17,120

10,002

24,527

Professional fees

181

125

397

626

Foreign exchange (gain)/loss

(6)

10

(3)

5

Interest and other income

(125)

(72)

(319)

(642)

Comprehensive loss

5,819

17,850

11,996

26,590

v3.23.3
Accounts payable and accrued liabilities
9 Months Ended
Aug. 31, 2023
Accounts payable and accrued liabilities.  
Accounts payable and accrued liabilities

4)    Accounts payable and accrued liabilities

in thousands of dollars  

August 31, 2023

November 30, 2022

  

$

  

  

$

  

Trade accounts payable

92

188

Accrued liabilities

 

94

 

36

Accrued salaries and vacation

 

296

 

121

Accounts payable and accrued liabilities

 

482

 

345

Of the accrued salaries and vacation approximately $166,000 was settled, subsequent to the end of the third quarter, on September 1, 2023 through the issuance of common shares of the Company.

v3.23.3
Leases
9 Months Ended
Aug. 31, 2023
Leases  
Leases

5)    Leases

(a)Right-of-use asset

in thousands of dollars

  

$

  

Balance as at November 30, 2022

319

Net amortization

(131)

Balance as at August 31, 2023

188

(b)Lease liabilities

The Company’s lease arrangements primarily consist of an operating lease for our office space ending in June 2024. There are no extension options.

Total lease expense recorded within general and administrative expenses was comprised of the following components:

    

in thousands of dollars

Nine months ended

Nine months ended

August 31, 2023

August 31, 2022

$

  

  

$

  

Operating lease costs

140

140

Variable lease costs

103

108

Total lease expense

243

248

Variable lease costs consist primarily of the Company’s portion of operating costs associated with the office space lease as the Company elected to apply the practical expedient not to separate lease and non-lease components.

As at August 31, 2023, the weighted-average remaining lease term is 0.6 years and the weighted-average discount rate is 8%. Significant judgment was used in the determination of the incremental borrowing rate which included estimating the Company’s credit rating.

Supplemental cash and non-cash information relating to our leases during the nine-month period ending August 31, 2023 are as follows:

Cash paid for amounts included in the measurement of lease liabilities was $149,102.

Future minimum payments relating to the lease recognized in our balance sheet as of August 31, 2023 are as follows:

    

in thousands of dollars

August 31, 2023

 

Fiscal year

$

  

2023

 

51

2024

 

33

2025

 

Total undiscounted lease payments

 

84

Effect of discounting

 

(2)

Present value of lease payments recognized as lease liability

 

82

v3.23.3
Share capital
9 Months Ended
Aug. 31, 2023
Share capital.  
Share capital

6)    Share capital

Authorized:

unlimited common shares, no par value

in thousands of dollars, except share amounts

Number of shares

Ascribed value

    

  

  

$

  

November 30, 2022

 

146,225,035

182,178

Private Placement, net of share issue cost

5,854,545

3,115

Restricted Share Units

2,807,921

1,780

Deferred Share Units

415,056

468

NovaGold deferred share units conversion

1,130

3

Services settled by common shares

112,142

60

Joint venture equity contribution (note 3(b))

143,505

111

August 31, 2023, issued and outstanding

155,559,334

187,715

On April 30, 2012, under the NovaGold Arrangement, Trilogy committed to issue common shares to satisfy holders of NovaGold deferred share units (“NovaGold DSUs”), once vested, on record as of the close of business April 27, 2012. When vested, Trilogy committed to deliver one common share to the holder for every six shares of NovaGold the holder is entitled to receive, rounded down to the nearest whole number. As at August 31, 2023, a total of 5,144 NovaGold DSUs remain outstanding representing a right to receive 859 Common Shares in Trilogy, which will settle upon certain directors retiring from NovaGold’s board.

(a)

Common shares issuance

On April 25, 2023, the Company completed a non-brokered private placement of 5,854,545 common shares of the Company (the “Common Share”) at a price of $0.55 per Common Share for gross proceeds of $3.2 million and net proceeds of $3.1 million.  Financing costs consisted of legal and stock exchange fees.

(b)

Stock options

During the three-month period ended February 28, 2023, the Company granted 3,230,000 stock options (2022 - 1,734,500 stock options) at an exercise price of CDN$0.78 (2022 - CDN$2.21) to employees, consultants and directors exercisable for a period of five years with various vesting terms from immediate vesting to vesting over a two-year period. The fair value attributable to this option grants was CDN$0.37 (2022 - CDN$0.94).   There were no stock options granted during the second and third quarters.

For the nine-month period ended August 31, 2023, Trilogy recognized a stock-based compensation charge of $0.8 million (2022 - $1.4 million) for options granted to directors, employees and service providers, net of estimated forfeitures.

The fair value of the stock options recognized in the period has been estimated using the Black-Scholes option pricing model.

Assumptions used in the pricing model for the nine-month period ended August 31, 2023 are as provided below.

    

August 31, 2023

Risk-free interest rates

 

3.49%

Exercise price

 

CDN$0.78

Expected life

 

3 years

Expected volatility

 

67.7%

Expected dividends

 

Nil

As at August 31, 2023, there were 2,131,757 non-vested options outstanding with a weighted average exercise price of CDN$1.02; the non-vested stock option expense not yet recognized was $0.24 million. This expense is expected to be recognized over the next 16 months.

A summary of the Company’s stock option outstanding and changes during the nine-month period ended August 31, 2023 is as follows:

August 31, 2023

Weighted average

exercise price

    

Number of options

  

  

CDN$

  

Balance – beginning of the period

 

11,225,400

2.49

Granted

 

3,230,000

0.78

Cancelled

 

(286,000)

2.70

Expired

 

(1,170,000)

1.43

Balance – end of the period

 

12,999,400

2.16

There were no stock options exercised during the nine-month period ended August 31, 2023.

The following table summarizes information about the stock options outstanding at August 31, 2023.

Outstanding

Exercisable

Unvested

 

Weighted

Weighted

 

Number of

Weighted

average

Number of

average

Number of

 

outstanding

average years

exercise price

exercisable

exercise price

unvested

Range of exercise price - CDN

  

options

  

  

to expiry

  

  

CDN$

  

  

options

  

  

CDN$

  

  

options  

  

$0.75 to $1.00

 

3,230,000

4.27

0.78

1,463,328

0.78

1,766,672

$2.01 to $2.50

 

2,270,250

2.56

2.27

1,905,165

2.28

365,085

$2.51 to $3.00

6,041,650

1.73

2.64

6,041,650

2.64

$3.01 to $3.50

1,457,500

1.31

3.03

1,457,500

3.03

12,999,400

2.46

2.16

10,867,643

2.38

2,131,757

The aggregate intrinsic value of vested stock options (the market value less the exercise price) at August 31, 2023 was $Nil (2022 - $Nil) and the aggregate intrinsic value of exercised options for the nine-month period ending August 31, 2023 was $Nil (2022 - $0.05 million).

(c)

Restricted Share Units and Deferred Share Units

The Company has a Restricted Share Unit Plan (“RSU Plan”) to provide long-term incentives to employees and consultants and a Non-Executive Director Deferred Share Unit Plan (“DSU Plan”) to offset cash payments for fees to directors.  Awards under the RSU Plan and DSU Plan have been settled in common shares of the Company with each restricted share unit (“RSU”) and deferred share unit (“DSU”) entitling the holder to receive one common share of the Company.  All units are accounted for as equity-settled awards.

A summary of the Company’s unit plans and changes during the nine-month period ending August 31, 2023 is as follows:

    

Number of RSUs

  

  

Number of DSUs

  

Balance – beginning of the period

257,268

 

1,560,734

Granted

 

4,273,433

1,107,895

Vested/Converted

 

(2,920,063)

(415,056)

Balance – end of the period

 

1,610,638

 

2,253,573

For the nine-month period ending August 31, 2023, Trilogy recognized a combined RSU and DSU stock-based compensation charge of $2.0 million (2022 - $1.6 million), net of estimated forfeitures.

v3.23.3
Financial instruments
9 Months Ended
Aug. 31, 2023
Financial instruments  
Financial instruments

7)    Financial instruments

The Company is exposed to a variety of risks arising from financial instruments. These risks and management’s objectives, policies and procedures for managing these risks are disclosed as follows.

The Company’s financial instruments consist of cash, accounts receivable, deposits, and accounts payable and accrued liabilities. The fair value of the Company’s financial instruments approximates their carrying value due to the short-term nature of their maturity. The Company’s financial instruments initially measured at fair value and then held at amortized cost include cash, accounts receivable, deposits, and accounts payable and accrued liabilities.

Financial risk management

The Company’s activities expose it to certain financial risks, including currency risk, credit risk, liquidity risk, interest risk and price risk.

(a)

Currency risk

Currency risk is the risk of a fluctuation in financial asset and liability settlement amounts due to a change in foreign exchange rates. The Company operates in the United States and Canada. The Company’s exposure to currency risk at August 31, 2023 is limited to the Canadian dollar balances consisting of cash of approximately CDN$126,000, accounts receivable of approximately CDN$12,000 and accounts payable of approximately CDN$340,000. Based on a 10% change in the US-Canadian exchange rate, assuming all other variables remain constant, the Company’s net loss would change by approximately $14,000.

(b)

Credit risk

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company holds cash with a Canadian chartered financial institution of which the majority is uninsured as at August 31, 2023. The Company’s only significant exposure to credit risk is equal to the balance of cash as recorded in the financial statements.

(c)

Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulties raising funds to meet its financial obligations as they fall due. The Company is in the exploration stage and does not have cash inflows from operations; therefore, the Company manages liquidity risk through the management of its capital structure and financial leverage.

Contractually obligated undiscounted cash flow requirements as at August 31, 2023 are as follows:

in thousands of dollars

  

  

Total

  

  

< 1 Year

  

  

1–2 Years

  

  

2–5 Years

  

  

Thereafter

  

$

$

$

$

$

Accounts payable and accrued liabilities

 

482

 

482

 

Office lease

 

84

84

 

 

566

 

566

 

Included in accounts payable and accrued liabilities approximately $166,000 is for accrued salaries that were settled, subsequent to the end of the third quarter, on September 1, 2023 through the issuance of common shares of the Company (note 9).

(d)

Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk with respect to interest earned on cash. Based on balances as at August 31, 2023, a 1% change in interest rates would result in a negligible change in net loss, assuming all other variables remain constant.

As we are currently in the exploration phase none of our financial instruments are exposed to commodity price risk; however, our ability to obtain long-term financing and its economic viability could be affected by commodity price volatility.

v3.23.3
Commitment
9 Months Ended
Aug. 31, 2023
Commitment  
Commitment

8)    Commitment

The Company has commitments with respect to an office lease requiring future minimum lease payments as summarized in note 5(b) above.

v3.23.3
Subsequent event
9 Months Ended
Aug. 31, 2023
Subsequent event.  
Subsequent event

9) Subsequent event

On September 1, 2023, pursuant to previous elections, the Board of Directors were granted 175,127 DSUs in settlement of approximately $82,750 of director fees and senior management were granted 283,693 RSUs in lieu of cash salaries of approximately $166,000, all vesting immediately. The grants were in support of an effort to preserve cash and increase share ownership by settling director fees and a portion of senior management salaries in shares of the Company.

v3.23.3
Summary of significant accounting policies (Policies)
9 Months Ended
Aug. 31, 2023
Summary of significant accounting policies  
Basis of presentation

Basis of presentation

These interim consolidated financial statements have been prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Trilogy and its wholly owned subsidiaries, NovaCopper US Inc. (dba “Trilogy Metals US”) and 995 Exploration Inc. All intercompany transactions are eliminated on consolidation. For variable interest entities (“VIEs”) where Trilogy is not the primary beneficiary, we use the equity method of accounting.

All figures are in United States dollars unless otherwise noted. References to CDN$ refer to amounts in Canadian dollars.

These interim consolidated financial statements include all adjustments necessary for the fair presentation of the Company’s financial position as of August 31, 2023 and our results of operations and cash flows for the nine-month period ended August 31, 2023 and August 31, 2022. The results of operations for the nine-month period ended August 31, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending November 30, 2023.

As these interim consolidated financial statements do not contain all of the disclosures required by U.S. GAAP for annual financial statements, these interim consolidated financial statements should be read in conjunction with the annual financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended November 30, 2022, filed with the U.S. Securities and Exchange Commission (“SEC”) and Canadian securities regulatory authorities on February 14, 2023.

These interim consolidated financial statements were approved by the Company’s Audit Committee on behalf of the Board of Directors for issue on October 10, 2023.

Use of estimates and measurement uncertainties

Use of estimates and measurement uncertainties

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions of future events that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of expenditures during the period. Significant judgments include the assessment of potential indicators of impairment for our equity method investments where key judgement is the delay on the Ambler Access Project is temporary and the delay was considered when assessing indicators of impairment. Significant estimates include the measurement of income taxes, and the valuation of stock-based compensation. Actual results could differ materially from those reported.

Management assesses the possibility of impairment in the carrying value of its equity method investment in Ambler Metals whenever events or circumstances indicate that the carrying amount of the investment may not be recoverable. Significant judgments are made in assessing the possibility of impairment. Factors that may be indicative of an impairment include a loss in the value of an investment that is not temporary. Management considers several factors in considering if an indicator of impairment has occurred, including but not limited to, sustained losses by the investment, the absence of the ability to recover the carrying amount of the investment, significant changes in the legal, business or regulatory environment, significant adverse changes impacting the investee and internal reporting indicating the economic performance of an investment is, or will be, worse than expected. 

These factors are subjective and require consideration at each period end.

v3.23.3
Investment in Ambler Metals LLC (Tables)
9 Months Ended
Aug. 31, 2023
Investment in Ambler Metals LLC  
Schedule of equity investment

    

in thousands of dollars

$

  

November 30, 2022, Investment in Ambler Metals

142,754

Joint venture equity contribution

111

Share of loss on equity investment for the nine-month period ending August 31, 2023

(5,998)

August 31, 2023, Investment in Ambler Metals

136,867

Schedule of Ambler Metals LLC's Balance Sheet

    

in thousands of dollars

August 31, 2023

November 30, 2022

    

$

  

  

$

  

Total assets

102,140

114,049

Cash

66,866

80,755

Mineral properties

30,899

30,899

Total liabilities

(4,200)

(4,335)

Accounts payable and accrued liabilities

(3,707)

(3,664)

Members' equity (total assets less total liabilities)

97,940

109,714

Schedule of Ambler Metals LLC's net loss

in thousands of dollars

Three months ended

Nine months ended

August 31, 2023

August 31, 2022

August 31, 2023

August 31, 2022

  

$

  

  

$

  

  

$

  

  

$

  

Depreciation

38

32

113

77

Corporate salaries and wages

478

477

1,417

1,437

General and administrative

43

158

389

560

Mineral property expense

5,210

17,120

10,002

24,527

Professional fees

181

125

397

626

Foreign exchange (gain)/loss

(6)

10

(3)

5

Interest and other income

(125)

(72)

(319)

(642)

Comprehensive loss

5,819

17,850

11,996

26,590

v3.23.3
Accounts payable and accrued liabilities (Tables)
9 Months Ended
Aug. 31, 2023
Accounts payable and accrued liabilities.  
Schedule of accounts payable and accrued liabilities

in thousands of dollars  

August 31, 2023

November 30, 2022

  

$

  

  

$

  

Trade accounts payable

92

188

Accrued liabilities

 

94

 

36

Accrued salaries and vacation

 

296

 

121

Accounts payable and accrued liabilities

 

482

 

345

v3.23.3
Leases (Tables)
9 Months Ended
Aug. 31, 2023
Leases  
Schedule of right-of-use asset

in thousands of dollars

  

$

  

Balance as at November 30, 2022

319

Net amortization

(131)

Balance as at August 31, 2023

188

Schedule of lease expenses

    

in thousands of dollars

Nine months ended

Nine months ended

August 31, 2023

August 31, 2022

$

  

  

$

  

Operating lease costs

140

140

Variable lease costs

103

108

Total lease expense

243

248

Schedule of future minimum payments

    

in thousands of dollars

August 31, 2023

 

Fiscal year

$

  

2023

 

51

2024

 

33

2025

 

Total undiscounted lease payments

 

84

Effect of discounting

 

(2)

Present value of lease payments recognized as lease liability

 

82

v3.23.3
Share capital (Tables)
9 Months Ended
Aug. 31, 2023
Share capital.  
Schedule of common stock outstanding roll forward

in thousands of dollars, except share amounts

Number of shares

Ascribed value

    

  

  

$

  

November 30, 2022

 

146,225,035

182,178

Private Placement, net of share issue cost

5,854,545

3,115

Restricted Share Units

2,807,921

1,780

Deferred Share Units

415,056

468

NovaGold deferred share units conversion

1,130

3

Services settled by common shares

112,142

60

Joint venture equity contribution (note 3(b))

143,505

111

August 31, 2023, issued and outstanding

155,559,334

187,715

Schedule of assumptions used in the pricing model

    

August 31, 2023

Risk-free interest rates

 

3.49%

Exercise price

 

CDN$0.78

Expected life

 

3 years

Expected volatility

 

67.7%

Expected dividends

 

Nil

Summary of the company's stock option plan

August 31, 2023

Weighted average

exercise price

    

Number of options

  

  

CDN$

  

Balance – beginning of the period

 

11,225,400

2.49

Granted

 

3,230,000

0.78

Cancelled

 

(286,000)

2.70

Expired

 

(1,170,000)

1.43

Balance – end of the period

 

12,999,400

2.16

Summary of information about stock options

Outstanding

Exercisable

Unvested

 

Weighted

Weighted

 

Number of

Weighted

average

Number of

average

Number of

 

outstanding

average years

exercise price

exercisable

exercise price

unvested

Range of exercise price - CDN

  

options

  

  

to expiry

  

  

CDN$

  

  

options

  

  

CDN$

  

  

options  

  

$0.75 to $1.00

 

3,230,000

4.27

0.78

1,463,328

0.78

1,766,672

$2.01 to $2.50

 

2,270,250

2.56

2.27

1,905,165

2.28

365,085

$2.51 to $3.00

6,041,650

1.73

2.64

6,041,650

2.64

$3.01 to $3.50

1,457,500

1.31

3.03

1,457,500

3.03

12,999,400

2.46

2.16

10,867,643

2.38

2,131,757

Schedule of restricted share Units and deferred share units plans

    

Number of RSUs

  

  

Number of DSUs

  

Balance – beginning of the period

257,268

 

1,560,734

Granted

 

4,273,433

1,107,895

Vested/Converted

 

(2,920,063)

(415,056)

Balance – end of the period

 

1,610,638

 

2,253,573

v3.23.3
Financial instruments (Tables)
9 Months Ended
Aug. 31, 2023
Financial instruments  
Schedule of contractually obligated cash flow requirements

in thousands of dollars

  

  

Total

  

  

< 1 Year

  

  

1–2 Years

  

  

2–5 Years

  

  

Thereafter

  

$

$

$

$

$

Accounts payable and accrued liabilities

 

482

 

482

 

Office lease

 

84

84

 

 

566

 

566

 

v3.23.3
Investment in Ambler Metals LLC - Narrative (Details)
3 Months Ended 9 Months Ended
Feb. 11, 2020
USD ($)
Owner
Aug. 31, 2023
USD ($)
shares
Aug. 31, 2022
USD ($)
Aug. 31, 2023
USD ($)
shares
Aug. 31, 2022
USD ($)
Nov. 30, 2022
USD ($)
Schedule of Equity Method Investments [Line Items]            
Comprehensive (loss) earnings for the year   $ (4,052,000) $ (9,938,000) $ (11,927,000) $ (19,035,000)  
Investment in Ambler Metals   136,867,000   136,867,000   $ 142,754,000
Ambler Metals LLC            
Schedule of Equity Method Investments [Line Items]            
Joint venture, contributed amount   111,000   111,000    
Contribution made to joint venture   $ 111,000   $ 111,000    
Joint venture contribution made in common shares | shares   143,505   143,505    
Percentage of ownership 50.00% 50.00%   50.00%    
Comprehensive (loss) earnings for the year   $ (5,800,000) $ (17,900,000) $ (12,000,000.0) $ (26,600,000)  
Number of board members | Owner 4          
Number of members appointed by Trilogy | Owner 2          
Investment in Ambler Metals $ 176,000,000 136,867,000   136,867,000    
Maximum exposure to loss   136,900,000   136,900,000    
Fair value ascribed to Ambler Metals LLC interest           $ 142,754,000
South32 | Ambler Metals LLC            
Schedule of Equity Method Investments [Line Items]            
Contribution made to joint venture   $ 111,000   $ 111,000    
Percentage of ownership 50.00% 50.00%   50.00%    
South32            
Schedule of Equity Method Investments [Line Items]            
Contribution made to joint venture $ 145,000,000          
v3.23.3
Investment in Ambler Metals LLC - Financial information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 31, 2023
Aug. 31, 2022
Aug. 31, 2023
Aug. 31, 2022
Nov. 30, 2022
Feb. 11, 2020
The carrying value of equity method investment            
Share of loss on equity investment $ (2,910) $ (8,925) $ (5,998) $ (13,295)    
Investment in Ambler Metals 136,867   136,867   $ 142,754  
Assets [Abstract]            
Total assets 140,577   140,577   145,995  
Cash 3,049   3,049   2,573  
Liabilities [Abstract]            
Total liabilities (564)   (564)   (567)  
Ambler Metals' Net Loss            
General and administrative 278 279 1,014 1,014    
Professional Fees 139 131 897 568    
Foreign exchange (gain) loss 3 (11) 1 (7)    
Ambler Metals            
Assets [Abstract]            
Total assets 102,140   102,140   114,049  
Cash 66,866   66,866   80,755  
Mineral properties 30,899   30,899   30,899  
Liabilities [Abstract]            
Total liabilities (4,200)   (4,200)   (4,335)  
Accounts payable and accrued liabilities (3,707)   (3,707)   (3,664)  
Members' equity (total assets less total liabilities) 97,940   97,940   109,714  
Ambler Metals' Net Loss            
Depreciation 38 32 113 77    
Corporate salaries and wages 478 477 1,417 1,437    
General and administrative 43 158 389 560    
Mineral property expense 5,210 17,120 10,002 24,527    
Professional Fees 181 125 397 626    
Foreign exchange (gain) loss (6) 10 (3) 5    
Interest and other income 125 72 319 642    
Comprehensive loss 5,819 $ 17,850 11,996 $ 26,590    
Ambler Metals LLC            
The carrying value of equity method investment            
Investment in Ambler Metals         $ 142,754  
Joint venture, contributed amount 111   111      
Share of loss on equity investment     (5,998)      
Investment in Ambler Metals $ 136,867   $ 136,867     $ 176,000
v3.23.3
Accounts payable and accrued liabilities (Details) - USD ($)
Sep. 01, 2023
Aug. 31, 2023
Nov. 30, 2022
Subsequent Event [Line Items]      
Trade accounts payable   $ 92,000 $ 188,000
Accrued liabilities   94,000 36,000
Accrued salaries and vacation   296,000 121,000
Accounts payable and accrued liabilities   $ 482,000 $ 345,000
Subsequent Event      
Subsequent Event [Line Items]      
Accrued salaries and vacation $ 166,000    
v3.23.3
Leases - Narrative (Details)
9 Months Ended
Aug. 31, 2023
USD ($)
Leases  
Lessee, Operating Lease, Existence of Option to Extend [true false] false
Weighted-average remaining lease term 7 months 6 days
Weighted-average discount rate 8.00%
Cash paid for amounts included in the measurement of lease liabilities $ 149,102
v3.23.3
Leases - Right of use asset (Details)
$ in Thousands
9 Months Ended
Aug. 31, 2023
USD ($)
Leases  
Balance, beginning $ 319
Net amortization (131)
Balance, ending $ 188
v3.23.3
Leases - Lease liabilities (Details) - USD ($)
$ in Thousands
9 Months Ended
Aug. 31, 2023
Aug. 31, 2022
Leases    
Operating lease costs $ 140 $ 140
Variable lease costs 103 108
Total lease expense $ 243 $ 248
v3.23.3
Leases - Future minimum payments (Details)
$ in Thousands
Aug. 31, 2023
USD ($)
Future minimum payments  
2023 $ 51
2024 33
Total undiscounted lease payments 84
Effect of discounting (2)
Present value of lease payments recognized as lease liability $ 82
v3.23.3
Share capital - Narrative (Details)
3 Months Ended 9 Months Ended
Apr. 25, 2023
USD ($)
$ / shares
shares
Aug. 31, 2023
USD ($)
$ / shares
shares
May 31, 2023
USD ($)
shares
Feb. 28, 2023
USD ($)
shares
Feb. 28, 2023
$ / shares
Aug. 31, 2022
USD ($)
May 31, 2022
USD ($)
shares
Feb. 28, 2022
USD ($)
shares
Feb. 28, 2022
$ / shares
Aug. 31, 2023
USD ($)
$ / shares
shares
Aug. 31, 2022
USD ($)
Aug. 31, 2023
$ / shares
Nov. 30, 2022
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Number of shares, conversion                   1      
Non-vested stock options outstanding   12,999,400               12,999,400      
Private placement, net proceeds | $                   $ 3,115,000      
Stock-based compensation | $   $ (393,000) $ (371,000) $ (2,220,000)   $ (571,000) $ (503,000) $ (1,865,000)          
Weighted average exercise price options outstanding | $ / shares   $ 2.16               $ 2.16      
Period for recognition of stock compensation expense                   16 months      
Aggregate intrinsic value, vested options | $   $ 0               $ 0      
Aggregate intrinsic value, options exercised | $                   $ 0 $ 50,000.00    
Share capital                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Common stock committed for issuance   155,559,334               155,559,334     146,225,035
Shares issued for private placement, net of share issue cost (Shares) 5,854,545   5,854,545             5,854,545      
Price per common share | $ / shares $ 0.55                        
Private placement, gross proceeds | $ $ 3,200,000                        
Private placement, net proceeds | $ $ 3,100,000                        
Exercise of options, Number of shares             50,000 31,674          
Nonvested Options                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Non-vested stock options outstanding   2,131,757               2,131,757      
Weighted average exercise price options outstanding | $ / shares                       $ 1.02  
Stock option expense not yet recognized | $   $ 240,000               $ 240,000      
DSUs                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Stock-based compensation | $                   $ 2,000,000.0 1,600,000    
Stock option                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Non-vested stock options outstanding   12,999,400               12,999,400     11,225,400
Weighted average exercise price options outstanding | $ / shares   $ 2.16               $ 2.16     $ 2.49
Exercise of options, Number of shares                   0      
Stock options granted                   3,230,000      
Weighted-average exercise price | $ / shares                   $ 0.78      
Employees, consultants and directors                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Stock options granted, expiration period       5 years                  
Stock options granted   0 0 3,230,000       1,734,500          
Vesting period       2 years                  
Weighted-average exercise price | $ / shares         $ 0.78       $ 2.21        
Stock options granted, weighted average fair value | $ / shares         $ 0.37       $ 0.94        
Directors, employees and service providers                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Stock-based compensation | $                   $ 800,000 $ 1,400,000    
Directors, employees and service providers | NovaGold Arrangement                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Number of shares, conversion                   6      
Directors, employees and service providers | NovaGold Arrangement | Nonvested Options                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Non-vested stock options outstanding   5,144               5,144      
Common stock committed for issuance   859               859      
v3.23.3
Share capital - Authorized unlimited common shares, no par value (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Apr. 25, 2023
Aug. 31, 2023
May 31, 2023
Feb. 28, 2023
Aug. 31, 2022
May 31, 2022
Feb. 28, 2022
Aug. 31, 2023
Nov. 30, 2022
Class of Stock [Line Items]                  
Unlimited common shares authorized               Unlimited Unlimited
Common Stock, No Par Value   $ 0           $ 0 $ 0
Private Placement, net of share issue cost, Ascribed value     $ 3,115            
Services settled by common shares, Ascribed value   $ 20 $ 35 $ 4          
Share capital                  
Class of Stock [Line Items]                  
Exercise of options, Number of shares           50,000 31,674    
Private Placement, net of share issue cost, Number of shares 5,854,545   5,854,545         5,854,545  
Private Placement, net of share issue cost, Ascribed value     $ 3,115         $ 3,115  
Restricted share units, Number of shares   248,092 213,463 2,346,366 244,216 110,000 391,332 2,807,921  
Restricted share units, Ascribed value               $ 1,780  
Deferred share units, Number of shares               415,056  
Deferred share units, Ascribed value               $ 468  
NovaGold deferred share units conversion, Number of shares   1,130           1,130  
NovaGold deferred share units conversion, Ascribed value   $ 3           $ 3  
Services settled by common shares, Number of shares   40,816 63,533 7,793       112,142  
Services settled by common shares, Ascribed value   $ 20 $ 35 $ 4       $ 60  
Joint venture equity contribution (note 3(b)), Number of shares       143,505     31,469 143,505  
Joint venture equity contribution (note 3(b)), Ascribed value   $ 111           $ 111  
Ending balance, Number of shares outstanding   155,559,334           155,559,334 146,225,035
Beginning balance, Number of shares       146,225,035       146,225,035  
Ending balance, Ascribed value   $ 187,715           $ 187,715 $ 182,178
Beginning balance, Ascribed value       $ 182,178       $ 182,178  
Contributed surplus.                  
Class of Stock [Line Items]                  
NovaGold deferred share units conversion, Ascribed value   $ (3)              
v3.23.3
Share capital - Assumptions used in the pricing model (Details)
9 Months Ended
Aug. 31, 2023
$ / shares
Share capital.  
Risk-free interest rates 3.49%
Exercise price $ 0.78
Expected life 3 years
Expected volatility 67.70%
Expected dividends
v3.23.3
Share capital - Stock options plans and changes (Details)
9 Months Ended
Aug. 31, 2023
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Balance - end of period, number of options 12,999,400
Balance - end of period, weighted average exercise price | $ / shares $ 2.16
Stock option  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Balance - beginning of the year, number of options 11,225,400
Balance - beginning of the year, weighted average exercise price | $ / shares $ 2.49
Number of options, Granted 3,230,000
Weighted average exercise price, Granted | $ / shares $ 0.78
Number of options, Exercised 0
Number of options, Cancelled (286,000)
Weighted average exercise price, Cancelled | $ / shares $ 2.70
Number of options, Expired (1,170,000)
Weighted average exercise price, Expired | $ / shares $ 1.43
Balance - end of period, number of options 12,999,400
Balance - end of period, weighted average exercise price | $ / shares $ 2.16
v3.23.3
Share capital - Stock options outstanding (Details)
9 Months Ended
Aug. 31, 2023
$ / shares
shares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number of outstanding options | shares 12,999,400
Weighted average years to expiry 2 years 5 months 15 days
Weighted average exercise price options outstanding $ 2.16
Number of exercisable options | shares 10,867,643
Weighted average exercise price exercisable $ 2.38
Number of unvested options | shares 2,131,757
$0.75 to $1.00  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price lower range limit $ 0.75
Exercise price upper range limit $ 1.00
Number of outstanding options | shares 3,230,000
Weighted average years to expiry 4 years 3 months 7 days
Weighted average exercise price options outstanding $ 0.78
Number of exercisable options | shares 1,463,328
Weighted average exercise price exercisable $ 0.78
Number of unvested options | shares 1,766,672
$2.01 to $2.50  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price lower range limit $ 2.01
Exercise price upper range limit $ 2.50
Number of outstanding options | shares 2,270,250
Weighted average years to expiry 2 years 6 months 21 days
Weighted average exercise price options outstanding $ 2.27
Number of exercisable options | shares 1,905,165
Weighted average exercise price exercisable $ 2.28
Number of unvested options | shares 365,085
$2.51 to $3.00  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price lower range limit $ 2.51
Exercise price upper range limit $ 3.00
Number of outstanding options | shares 6,041,650
Weighted average years to expiry 1 year 8 months 23 days
Weighted average exercise price options outstanding $ 2.64
Number of exercisable options | shares 6,041,650
Weighted average exercise price exercisable $ 2.64
Number of unvested options | shares 0
$3.01 to $3.50  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price lower range limit $ 3.01
Exercise price upper range limit $ 3.50
Number of outstanding options | shares 1,457,500
Weighted average years to expiry 1 year 3 months 21 days
Weighted average exercise price options outstanding $ 3.03
Number of exercisable options | shares 1,457,500
Weighted average exercise price exercisable $ 3.03
Number of unvested options | shares 0
v3.23.3
Share capital - Unit plans and changes (Details)
9 Months Ended
Aug. 31, 2023
shares
RSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Balance - beginning of the period 257,268
Granted 4,273,433
Vested/Converted (2,920,063)
Balance - end of the period 1,610,638
DSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Balance - beginning of the period 1,560,734
Granted 1,107,895
Vested/Converted (415,056)
Balance - end of the period 2,253,573
v3.23.3
Financial instruments - Narrative (Details)
9 Months Ended
Aug. 31, 2023
USD ($)
Sep. 01, 2023
USD ($)
Aug. 31, 2023
CAD ($)
Nov. 30, 2022
USD ($)
Cash $ 3,049,000     $ 2,573,000
Accounts receivable $ 10,000     $ 17,000
Subsequent Event        
Accrued salaries   $ 166,000    
10% change in the US-Canadian exchange rate        
Cash     $ 126,000  
Accounts receivable     12,000  
Accounts payable     $ 340,000  
Change in foreign exchange rate 10.00%   10.00%  
Foreign exchange loss $ 14,000      
1% change in interest rates        
Change in interest rate 1.00%   1.00%  
v3.23.3
Financial instruments - Contractually obligated cash flow requirements (Details)
$ in Thousands
Aug. 31, 2023
USD ($)
Total $ 566
Less than 1 year 566
1 - 2 Years 0
2 - 5 Years 0
Thereafter 0
Accounts payable and accrued liabilities  
Total 482
Less than 1 year 482
1 - 2 Years 0
2 - 5 Years 0
Thereafter 0
Office lease  
Total 84
Less than 1 year 84
1 - 2 Years 0
2 - 5 Years 0
Thereafter $ 0
v3.23.3
Subsequent event (Details) - Subsequent Event
Sep. 01, 2023
USD ($)
shares
RSUs | Senior management  
Subsequent Event [Line Items]  
Cash salaries | $ $ 166,000
Granted (in shares) | shares 283,693
DSUs. | Director  
Subsequent Event [Line Items]  
Director fees | $ $ 82,750
Granted (in shares) | shares 175,127

Trilogy Metals (AMEX:TMQ)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Trilogy Metals Charts.
Trilogy Metals (AMEX:TMQ)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Trilogy Metals Charts.